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Background: Chronic pain is a worldwide problem that can cause a great level of disability in a person’s 
life. The aetiology of conditions such as fibromyalgia is still under debate, and there are many 
biological, psychological and social hypotheses for its development. Past research in this area has 
explored the predictive impact of abuse and post-traumatic stress, but these are just some of the 
factors implicated in a wider picture. Psychological approaches to chronic pain have focused on 
Cognitive Behavioural Therapy and Acceptance and Commitment Therapy, two approaches that result 
in similar outcomes. Currently, very little research exists on Compassion-Focused Therapy (CFT) for 
chronic pain, even though the literature suggests conceptual overlaps between CFT and existing 
therapies.  
Objective: This thesis aims to reconcile existing information on the psychosocial risk factors that lead 
to the development of fibromyalgia (Chapter 1) and evaluate the suitability of an 11-week 
Compassion-Focused Therapy group intervention for adults with chronic pain (Chapter 2). 
Furthermore, this research also seeks to explore self-compassion, psychological flexibility and 
psychological inflexibility as potential mediators of improvement in outcome. Limited research and 
clinical resources can be better used by focusing on how therapies work, instead of if they work against 
similar treatments that have already proven efficacious.  
Methods: The evidence base for psychosocial risk factors in the development of fibromyalgia is 
systematically reviewed in Chapter 1. Electronic databases were searched for various descriptions of 
fibromyalgia, risk factors and observational study designs. Populations that included physical co-
morbidities were excluded. In Chapter 2, 122 participants attended the Pain Management Programme 
at the NHS Lothian Chronic Pain Service. Outcome measures were collected at three timepoints (pre, 
mid and post-group). One-way ANOVAs were used to evaluate the efficacy of the intervention, along 
with multiple regressions to perform mediation analysis. 
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Results: 10 studies from a search of 889 potentially relevant studies met the inclusion criteria for 
systematic review. Most of these studies were deemed to be of good quality. Commonalities across 
studies included appropriate selection of control and comparison groups, valid random sampling 
techniques and adequate length to follow-up in the case of cohort studies. Studies, however, varied 
across their methods in ascertaining fibromyalgia and researchers relied on their own reports to 
establish outcomes. In Chapter 2, statistically significant improvements were demonstrated in 
measures of pain interference, anxiety, depression, psychological flexibility, psychological inflexibility, 
self-compassion and mental wellbeing by the end of the PMP. The largest improvements were found 
to occur in the second half of the PMP. Self-compassion was shown to mediate improvements in pain 
interference, whereas psychological flexibility and psychological inflexibility was shown to mediate 
improvements in depression and mental wellbeing. Neither predictor variable mediated 
improvements in anxiety.  
Discussion: Prospective cohort studies represent the best evidence for determining risk factors. 
Depression, anxiety, childhood adversity, work stress and low education were found to be risk factors 
for developing fibromyalgia. Based on these results, it is recommended that more conservative 
estimates of effect size be used. This research also provides evidence for the use of CFT as a group 
intervention for chronic pain. It can be concluded that pain interventions targeting psychological 
flexibility and psychological inflexibility are likely to be further improved by emphasising self-
compassion. CFT and ACT already share similar values, despite their differing theoretical backgrounds. 
Patients will be able to benefit from a combined approach since self-compassion, psychological 





Lay Summary  
Chronic pain is pain that lasts longer than 3 months. Unlike acute pain, it is not an indicator of damage 
to the body. Fibromyalgia is a long-term condition that causes chronic pain all over the body, as well 
as other symptoms such as fatigue and problems with memory and concentration. The causes of 
fibromyalgia are still under debate, and Chapter 1 of this thesis compiles information about the 
psychological and social factors related to the development of fibromyalgia. The results in Chapter 1 
found that depression, anxiety, childhood adversity, work stress and low education were risk factors 
for developing fibromyalgia. 
Pain Management Programmes are a recommended group treatment for people with chronic pain, 
involving input from different professionals using exercise, education and psychological therapies. 
These multidisciplinary teams help people manage the negative experiences associated with living 
with chronic pain (such as distressing thoughts and feelings); the aim is not to get rid of the pain. Often 
people with chronic pain can feel shameful about their condition. Compassion-Focused Therapy (CFT) 
is a type of psychological treatment that helps people to view themselves and their difficulties in a 
kinder, less critical way (self-compassion). Currently, no research is available on the effectiveness of 
CFT in managing chronic pain. Research, however, does exist to show that there are elements of other 
treatments that overlap with elements of CFT. One example of this overlap is psychological flexibility. 
Psychological flexibility is the ability to recognise and adapt to life circumstances, by pursuing long-
term life values (e.g. being a supportive parent) instead of short-lived ones (e.g. avoiding pain).  
Chapter 2 aims to establish how CFT might work for people with chronic pain. This study aims to 
investigate self-compassion, psychological flexibility and psychological inflexibility as possible tools in 
the effectiveness of CFT on people with chronic pain. It was found that CFT is effective as a group 
intervention for chronic pain, and the largest improvements occurred in the second half of the group. 
Self-compassion explained improvements in pain interference; psychological flexibility and 
psychological inflexibility explained improvements in depression and mental wellbeing.  
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Objective: Previous research in this area has focused on the predictive impact of abuse and post-
traumatic stress on the risk of developing fibromyalgia. The aim of this systematic review is to 
synthesise information on the wider psychosocial risk factors for fibromyalgia syndrome (FM or FMS).  
Methods: Embase, EMCare, MEDLINE and PsycINFO were systematically searched for appropriate 
papers. Only published, peer-reviewed, English articles that focused on adult populations were 
included.  Search terms covered various descriptions of fibromyalgia, risk factors and observational 
study designs. Populations that included physical co-morbidities were excluded. A second reviewer 
independently assessed the quality of 3 papers (30%).  
Results: 10 studies from a search of 889 potentially relevant studies met inclusion criteria. Most of 
these studies were deemed to be of good quality. Meta-analysis was not possible due to the 
heterogeneity of study designs and outcome measures. Commonalities across studies included 
appropriate selection of control and comparison groups, valid random sampling techniques and 
adequate length to follow-up in the case of cohort studies. Studies, however, varied across their 
methods in ascertaining fibromyalgia and researchers relied on their own reports to establish 
outcomes. 
Discussion: Prospective cohort studies represent the best evidence for determining risk factors. 
Depression, anxiety, childhood adversity, work stress and low education were found to be risk factors 
for developing fibromyalgia. It is recommended that more conservative estimates of effect size be 
used in this area. Further associations were found between a number of variables, but due to 
limitations in study design, only inferences about these correlations can be made.  
 
Keywords 





Fibromyalgia (FM) or fibromyalgia syndrome (FMS) is characterised by a history of widespread pain of 
at least three months’ duration, and pain in 11 out of 18 specified tender points in the body. It is often 
associated with stiffness, sleep disturbances and fatigue, although diagnosis does not require all of 
these symptoms to be present at the same time1. Cognitive difficulties, especially in memory and 
learning (“fibro-fog”), and mood disturbances are also linked to the condition2,3. Central to 
fibromyalgia is an overly reactive and permanently altered nociceptive system4. Through a process of 
central sensitisation, pain sensitivity is heightened (hyperalgesia) and pain is experienced in response 
to typically innocuous stimuli (allodynia)5. 
Fibromyalgia is estimated to affect 2.6% of the population worldwide, and has been reported to be 
more prevalent in women, those over the age of 50, those with lower attainments in education and 
low socioeconomic status (see Queiroz6 for a synthesis of 26 prevalence studies worldwide). There is 
some disagreement about the relationship of these sociodemographic variables to the development 
of fibromyalgia7; study designs in this area of research are often not equipped to determine the 
timeline of risk factors. A prospective study by Davies et al.8 reported that the relationship between 
new chronic widespread pain and socioeconomic status can be attributed to psychological factors, 
which illustrates a complex picture of interrelated variables exacerbating long-term pain.  
Due to the heterogenous nature of fibromyalgia, its aetiology is debated and multi-layered. Genetic, 
neurohormonal and biological explanations have been proposed (e.g. serotoninergic, dopaminergic 
and catecholaminergic systems9; deep tissue impulse input10), however, the contributing 
psychological mechanisms are less clear. Anxiety and depression are associated with fibromyalgia11 
and high levels of psychological distress and illness behaviour (medical-care seeking and fatigue)12 
have been found to increase likelihood of persistent pain. Stress has been noted as a precipitating 
factor, but evidence for this is conflicting13. A narrative review by Gupta and Silman14 compiled 




neurotransmitters, which contributes to the development of the symptoms of fibromyalgia, such as 
pain and fatigue. Pre-morbid psychological disposition also contributes to sustaining these 
relationships, for example, inappropriate overactivity and perfectionistic traits perpetuate high levels 
of stress15.  
There are currently no systematic reviews that focus only on the psychosocial risk factors implicated 
in the development of fibromyalgia. An older Spanish review16 included studies up to 2007 and 
identified risk factors such as stress and occupation, and other physical risk factors such as Hepatitis 
C and smoking. Seven of the included papers in Restrepo-Medrano’s16 review were theoretical reviews 
and new empirical research has emerged since then. The aim of this current review is to collate 
existing and new research on the psychosocial risk factors, which can be defined as internal and 
individual (e.g. depression) or external and structural variables (e.g. work environment)17. 
Previous systematic reviews in this area have focused solely on the association between trauma and 
fibromyalgia18,19. Hauser et al.’s18 meta-analysis noted significant associations between physical and 
sexual abuse and fibromyalgia, but not emotional abuse. Low study quality was a confounding factor. 
The authors suggest that the indistinct nature of emotional abuse may be problematic to 
conceptualise and its definition varied across studies. Since depression is related to reported 
childhood emotional abuse20, it is significant that none of the included studies in Hauser’s systematic 
review looked at the effect of depression in reporting the incidence of abuse. 
A systematic review by Yarden et al.19 found significant associations between fibromyalgia and past 
physical or psychological trauma. They propose a model of genetic susceptibility, aggravated by 
physical, medical or psychological triggers, which leads to central sensitisation. In their model, the 
development of fibromyalgia and PTSD is mediated by factors such as gender and co-morbid 
psychopathology. Many of the studies included in Hauser’s18 and Yarden’s systematic reviews rely on 
retrospective data and are therefore limited in what conclusions can be drawn regarding the causality 




There is ongoing criticism around whether or not fibromyalgia should be considered a distinct 
classification from chronic widespread pain11, with some debating the psychogenic nature of the 
condition6. Fibromyalgia has been shown to be associated with more severe symptoms, greater 
limitations in function and fewer periods of remission21,22. It appears to represent an extreme end of 
the spectrum of chronic widespread pain, and as such, is treated as a separate entity in this review.  
1.1 Rationale 
To date, no systematic reviews have been published that focus solely on the psychosocial risk factors 
for developing fibromyalgia. Previous reviews in this area are either outdated16 or focus only on the 
relationship between trauma and fibromyalgia18,19. The aim of this systematic review is to synthesise 
empirical evidence on the psychosocial risk factors for developing fibromyalgia, which will include 
psychological, occupational and social factors. Observational study designs are reviewed as standard 
practice in risk factor research, since life and health events cannot be randomly assigned23. 
1.2 Review Question 
Based on existing observational research, what are the psychosocial risk factors that are implicated in 
the development of fibromyalgia? 
2. Method 
A systematic search of peer-reviewed literature was conducted; this protocol was registered on 
PROSPERO (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=119740) on the 25th 
January 2019.  
Guidance was taken from the Centre for Reviews and Dissemination 






2.1. Search Strategy 
 
Embase, EMCare, MEDLINE and PsycINFO were searched for appropriate papers in November 2018. 
No date limits were set and only papers published in English were included due to the impracticality 
of translation services. The following search terms were used: i) (“fibromyalgia” OR “fibromyalgia 
syndrome” OR “FM” OR “FMS” OR “widespread pain”) AND ii) (“risk factors” OR “predictors” OR 
“psychosocial factors” OR “psychological factors” AND iii) (“cross-sectional” OR “case-control” OR 
“cohort”). 889 papers were identified from this search. The PRISMA flowchart24 (Figure 1) details the 
process of appropriate paper identification.  
2.2. Inclusion and Exclusion Criteria 
 
Peer-reviewed studies were included based on the following criteria: 1) adult population (18+ years), 
2) specific focus on fibromyalgia (not widespread pain or other general chronic pain), 3) measurement 
of at least one psychosocial factor and 4) identification or analysis of risk of developing fibromyalgia. 
Studies were excluded if the target population was 1) children or adolescents, or 2) physical co-
morbidities (e.g. arthritis) and if the paper was a review article.  
2.3. Data Extraction 
 
Data was extracted using a form (Appendix 2) based on the STROBE Statement25, which covered 
information on a study’s methods (study design, size, participants, variables, data measurement and 
statistical methods), results (response rate, descriptive data and statistical analyses) and discussion 
(key results, limitations, strengths, interpretation and generalisability). Only psychosocial outcomes 





Figure 1 Literature search flowchart 
 






Papers excluded on basis 
of abstract/title 
(n=512) 
Full-text articles assessed 
for eligibility 
(n=65) 
Papers excluded on basis 
of full-text review 
(n=55) 
Final papers included 
(n=10) 
No measure of psychosocial variable (n=2) 
Co-morbid physical health (n=8) 
No information linking to risk of FMS (n=9) 
Not English (n=5) 
Outcome not relevant (n=4) 
Study is still ongoing (n=1) 
Child and/or adolescent population (n=2) 
Not specifically FM (n=15) 
Conference abstract (n=4) 
Narrative or systematic reviews (n=4) 




2.4. Quality Assessment 
 
The methodological quality of the included studies was assessed using criteria (Appendix 3) based on 
the Newcastle-Ottawa Quality Assessment Scale26 and Murray et al.’s23 recommendations for social 
scientists undertaking risk factor research. Quality was assessed over several areas: the study’s 
definition of fibromyalgia, sampling, data type, sample size, selection and definition of the non-
fibromyalgia group (where applicable), comparability, ascertainment of fibromyalgia, outcome, 
response rate and statistical testing. A quality criteria checklist was created based on these areas to 
consider the three different study designs in the final sample: cross-sectional, case-control and cohort. 
Each study was given an overall rating of risk of bias. A second reviewer independently rated the 
quality of 3 randomly selected papers. Disagreements were discussed and reconciled.  
3. Results 
 
3.1. Search Results 
889 potentially relevant studies were retrieved. 312 duplicates were removed and a further 512 
studies were excluded on the basis of title and abstract screening. 65 full-text studies were assessed 
for eligibility and 55 studies were excluded (reasons for these exclusions are detailed in Figure 1), 
leaving a final sample of 10 studies included in the review.  
3.2. Study Characteristics 
The main characteristics of the 10 studies are detailed in Table 1. Of these studies, 8 used original data 
(i.e. the study was deliberately designed to recruit participants for a pre-defined purpose, not using 
secondary data analysis). Two of the total studies were cross-sectional in design27,28, two were case-
control29,30 and six were cohort31–36. Most were based in Europe; three in the USA28,31,35 and one in 
Lebanon29. The populations being investigated were predominantly female (52.7-100%). Samples 




membership31 and one was based on a group of veterans28. Mean age across the sample ranged from 
27.7 to 49.2, where this information was available. Follow-up in cohort studies ranged from 2 to 25 
years. 
3.3. Quality Appraisal 
Table 2 illustrates the overall quality ratings of the 10 included studies, ordered by risk of bias 
expressed as a percentage of total available ‘+’ ratings; scores ranged from 56% to 92%. The lower 
rated studies indicated a higher risk of bias. Overall acceptability categories (such as ‘good’ and ‘poor’) 
were not assigned to individual studies due heterogeneity of study design. Most studies recruited 
adequate sample sizes28–36, controlled for relevant confounding variables27–34,36 and all employed 
appropriate statistical testing. Studies were generally found to be good quality, based on the ratio of 
positive to negative ratings. Studies that used a prospective study design31–34,36 were rated higher 
quality, due to the fact that risk factors could be measured before fibromyalgia was diagnosed, instead 
of relying on people’s retrospective recall. This is the ideal study design to deduce the time-ordering 
of variables in risk factor research. The prospective studies have been highlighted in Table 2, to 
indicate the difference in the quality of the evidence provided.  
Common weaknesses included: reliance on self-report measures28,31–34,36, inadequate method of 
ascertaining fibromyalgia31,33,34,36 and inadequate response rate (or absence of reporting the response 
rate)28–31,35. Suitability of response rate was guided by Richardson37 who suggested a 50% return rate 
on postal surveys is adequate in social science research. Five studies used the American College of 
Rheumatology (ACR)-1990 criteria to ascertain fibromyalgia27,29,30,32,34, two of which further employed 
medical examination to confirm the diagnosis27,29. All studies that employed a follow-up were found 
to be of suitable length31–34,36; according to existing research, 2 years is the average time until a 
diagnosis of fibromyalgia is made38. Other studies that cited a longer average time to diagnosis were 
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database 
analysis 
Depression [2.9 (2.7–3.1)] 
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Panic [3.3 (2.7–4.2)] 
PTSD [4.4 (3.4–5.9)] 
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Low income [ns] 
Having social support [0.47 (0.24–0.93)] 
Psychological distress [4.62 (2.68–7.97)] 
















from the same 
population 











Parental divorce [1.34 (1.05–1.72)] 
Financial difficulties [1.45 (1.18–1.77)] 
Serious conflict [1.40 (1.14–1.72)] 
Serious illness [1.27 (1.05–1.55)] 
Fear of family member [1.60 (1.28–2.01)] 
Alcohol problems [1.25 (1.02–1.53)] 
 
*Abbreviated measures: BDI: Beck Depression Inventory; CES-D: Centre for Epidemiologic Studies Depression Scale; CTQ: Childhood Trauma Questionnaire; GHQ-12: General Health Questionnaire; HS: Harris Scale of 
workload; LFESSQ: London Fibromyalgia Epidemiology Study Screening Instrument Questionnaire; PCL-M: Post Traumatic Checklist – Military; PDI: Pain Disability Index; PHQ-4: Patient Health Questionnaire; PSS: 
Perceived Stress Scale; PSQI: Pittsburgh Sleep Quality Index; SEI: Swedish Socioeconomic Classification; SF-12: Shortened Medical Outcomes Short Form Health Survey; SF-36: Medical Outcomes Short Form Health 































































































































































































                         
Authors (Year) Cross-Sectional 
D'Aoust (2017) - NA + + - + + NA - - NA + 56 
Bergman (2005) + NA - - - + + NA - + NA + 56 
 Retrospective 
Ruiz-Pérez (2009) - - + + + + + NA - - NA + 60 
Moukaddem (2015) + - + + + + + NA - - NA + 70 
Masters (2015) + - + + + - + + + NA - + 73 
 Prospective 
Choi (2010) - + + + + + - + + - + + 75 
Varinen (2017) + + + + - + - - + + + + 75 
Kivimaki (2004) - + + + + + - + - + + + 75 
Markkula (2016) + + + + - + - + - + + + 75 
Forseth (1999) + + + + + + + + - + + + 92 
 
3.4. Study Outcomes 
Study outcomes were heterogenous in nature and 17 psychosocial risk factors were identified. These 
risk factors were grouped into the following categories: psychological, occupational and social. Small 
(1.68), medium (3.47) and large (6.71) effect sizes for odds ratios are based on recommendations by 
Chen et al.40 and small (.02), medium (.13) and large (.26) effect sizes for eta squared calculations are 
based on recommendations by Bakeman41. Where possible, results from prospective studies have 




which are intrinsically prone to more bias. Findings from cross-sectional studies are reported last and 
termed as ‘associations', instead of predictive factors, in the absence of time-ordering in their design.   
3.4.1. Psychological Factors 
Forseth et al.’s prospective study32 found a small effect of anxiety [1.4 (0.3–5.8)] on the risk of 
developing fibromyalgia. This is supported by a retrospective longitudinal finding by Masters et al.35, 
who reported a higher likelihood of receiving a diagnosis of fibromyalgia one year following a diagnosis 
of anxiety, with a small-medium effect [2.6 (2.4–2.8)]. 
Forseth et al.32 reported a medium effect of self-assessed depression [3.3 (0.5–2.0)]. This is supported 
by another prospective study, Varinen et al.36, whose results showed a significant relationship 
between depression and fibromyalgia [p < 0.001], however, there was not enough information in the 
paper to calculate an effect size. This result was based on the Beck Depression Inventory (BDI42), 
contrasting with Forseth et al.’s32 single question regarding self-reported depression. A predictive link 
between depression and fibromyalgia [2.9 (2.7–3.1)] was highlighted in Masters et al.’s35 paper, 
however, causality cannot be confidently inferred due to its retrospective design. A large effect of 
depression was found by D’Aoust et al.28 [η2 = 0.2186, p < 0.0001], which also suffers from the same 
limitation as a cross-sectional study.  
Two retrospective studies explored psychological distress using the General Health Questionnaire (12-
item) (GHQ-1243): Ruiz-Perez et al.30 reported a medium effect [4.62 (2.68–7.97)] and Moukaddem et 
al.29 a small effect [1.45 (0.44–4.82)]. These two studies rated similarly on quality criteria, with the 
exception of the latter employing a better sampling strategy, more representative of fibromyalgia in 
the community, which suggests that a more conservative estimate may be more reliable. D’Aoust et 
al.’s28 cross-sectional study explored quality of life using the mental component of the Shortened 
Medical Outcomes Short Form Health Survey (SF-1244) and reported a large effect size [η2 = 0.1535,    
p < 0.005], highlighting a strong association between health related quality of life and fibromyalgia. 




of the SF-12 has been found to be better at screening anxiety and depression than the GHQ-1244. 
D’Aoust et al.28 did not find a significant association between stress and fibromyalgia.  
 A small effect size of workplace bullying [1.37 (0.81–2.31)] was found in Kivimaki’s33 prospective 
study, which may indicate the significance of emotional abuse. Ruiz-Perez et al.’s30 retrospective study 
explored frequent non-partner abuse as a risk factor, finding a medium effect [3.01 (0.84–10.97)], but 
did not distinguish between emotional, physical or sexual abuse. Post-traumatic stress disorder was 
found to have a large significant effect on receiving a diagnosis of fibromyalgia one year later [4.4 (3.4–
5.9)] in Masters et al.’s35 retrospective study. Incidence of military sexual trauma was not found to be 
significant, however, a large association was found between post-traumatic stress and fibromyalgia28 
[η2 = 0.1842, p = 0.0001], using the Post-Traumatic Checklist-Military (PCL-M45). 
Additionally, small-medium effect sizes of bipolar disorder [2.8 (2.2–3.6)], panic disorder [3.3 (2.7–
4.2)] and memory loss [2.4 (1.9–3.0)] were found to be predictive of a fibromyalgia diagnosis made 
one year later35, although there will be a degree of bias in these retrospective results. Out of the total 
psychiatric diagnoses investigated in this study, post-traumatic stress disorder was found to have the 
largest effect size. 
A small effect size of childhood adversities was reported across all the variables in one prospective 
study: parental divorce [1.34 (1.05–1.72)], financial difficulties [1.45 (1.18–1.77)], serious conflict [1.40 
(1.14–1.72)], serious or chronic illness [1.27 (1.05–1.55)], fear of a family member [1.60 (1.28–2.01)] 
and parental alcohol problems [1.25 (1.02–1.53)]36.  
3.4.2. Occupational Factors 
Three studies explored the impact of employment on the risk of developing fibromyalgia, ranging from 
no effect, small-medium and medium-large effect size29–31. The no effect finding by Choi et al.31 was 
reported in a higher rated prospective study, however, generalisability of findings may be limited as 




in two other studies29,30 were reported in retrospective studies. Due to study design, inferences cannot 
be made from these studies about the timeline of events and cannot be used to form conclusions 
about employment as a risk factor, only that there is a level of association. Unemployment was 
investigated as an additional factor in these two studies, with both reporting a non-significant 
result29,30. Low income was not found to be a significant risk factor across three methodologically 
weaker studies28–30. 
Kivimaki et al.’s33 prospective study investigated the effect of work stress on the incidence of 
fibromyalgia, using the Harris Scale46. Their findings report a small effect size of high workload [1.03 
(0.89–1.19)], low decision latitude [1.00 (0.82–1.24)] and workplace bullying [1.37 (0.81–2.31)] on the 
risk of developing fibromyalgia. Although this is only one study, this finding is relevant because its 
conclusions demonstrate the complexity of demographic information in this research; requesting 
information on employment status may not suffice when there is a varying spectrum of how 
occupation affects mental wellbeing.  
Low education was investigated by seven studies27,29–32,34,36. Of these findings, effect sizes ranged from 
no effect29,31 to small32, medium34 and large36. The higher rated quality studies32,34 were both 
prospective cohort designs, and therefore more equipped to comment on low education as a risk 
factor. These studies reported a more modest small and medium effect size of low education ([0.89 
(0.85–0.92)] and [2.6 (0.6–11.7)], respectively), indicating that a more conservative effect size should 
be considered when regarding the relationship between low education and the development of 
fibromyalgia. Bergman’s27 cross-sectional study did not report an effect size because all the 
participants in the smaller fibromyalgia group (n=15) belonged to the low education group and could 
not be compared with a high education group. It should be noted that low education was not assessed 
by D’Aoust et al.28, but since all participants in the study were veterans, they all had at least a high 





3.4.3. Social Factors 
Ruiz-Perez et al.’s30 retrospective study reported social support was related to a lower risk of 
fibromyalgia [0.47 (0.24–0.93)]. A small-medium sized association was found in a cross-sectional study 
between lack of social support and the development of fibromyalgia [2.4 (0.6–9.6)]27. Two studies 
found no effect of marital status31,36, however, one study found a medium effect size of marital 
separation [3.87 (1.93–7.73)]30. It should be noted that enquiry into marital separation has a different 
emotional quality to asking about overall marital status. In Varinen’s et al.’s36 study, single, divorced 
and widowed were all grouped into the same category. Ruiz-Perez et al.30 also found a medium effect 
size of being married [4.07 (2.46–6.75)], however, the purpose of this study was to investigate violence 
against women in the context of fibromyalgia, and 34.3% of fibromyalgia cases had disclosed intimate 
partner abuse. 
A small effect size was found for residence location [2.24 (0.71–7.05)] in Moukaddem et al.’s29 
retrospective study; those living in an urban environment were more likely to have fibromyalgia than 
those living in a rural environment.  Bergman’s27 cross-sectional findings illustrated a medium effect 
size of immigration [3.6 (0.8–16.6)] and a very large effect size of poor housing [18.1(1.9–168.6)] on 
the development of fibromyalgia. An effect size for socioeconomic status was not calculated because 
all the participants in the smaller fibromyalgia group belonged to the low socioeconomic status group.  
Bergman27 also enquired about an immediate family history of chronic pain and reported a large effect 
size [6.2 (1.8–21.0)]. He suggested that although there may be a genetic component to this result, 







17 potential psychosocial risk factors were identified across the 10 included studies in this systematic 
review. They were grouped under the following categories: psychological (anxiety, depression, 
distress, stress, post-traumatic stress, abuse, childhood adversities), occupational (work stress, 
employment, low income, low education) and social (social support, marital status, immigration, poor 
housing, residence location and family history). 
The most valid conclusions about risk factors are drawn from cohort studies that utilise prospective 
longitudinal designs. In order for a variable to be considered a risk factor, studies are required to 
establish a correlation that predates the diagnosis of fibromyalgia23. Five of the included studies in this 
review used this method31–34,36 and, therefore, their conclusions can be held with greater confidence 
than the retrospective or observational associations drawn from the other studies. These results show 
that depression, anxiety, childhood adversity, work stress and low education are risk factors for 
developing fibromyalgia. 
Although research into psychosocial risk factors for specifically fibromyalgia is scare, these results 
support the existing evidence base around chronic widespread pain. Measures of anxiety and 
depression have been implicated as risk factors47, as have adverse childhood events48,49, psychosocial 
factors in the workplace50 and low education51. Education and related sociodemographic variables are 
closely linked to health outcomes52, therefore, it is surprising that low income and unemployment 
were not found to be significant risk factors. These variables, along with the current review’s results 
of the large effect of poor housing27, may come under the wider umbrella of socioeconomic status. 
Those of low socioeconomic status are three times more likely to develop chronic widespread pain, 
although these relationships were explained in part by poor mental health and lifestyle factors53. 
Similarly, other studies have explained the relationship via adverse behavioural and social 
circumstances, such as smoking and low education54 and the impact of living in high social threat 




pronounced in populations of immigrants with pain56,57, which conveys the combined impact of 
multiple stressors in a situation exacerbating chronic pain conditions.  
Being diagnosed with memory loss or a psychiatric illness, especially PTSD, was found to predict a 
diagnosis of fibromyalgia one year later, although retrospective data is flawed by recall bias. There is 
a relationship between psychiatric distress and fibromyalgia (see Bradley58 for a review), but Aaron et 
al.59 raise an interesting point about this relationship. They demonstrated that ‘non-patients’ with 
fibromyalgia had a lower incidence of psychiatric history than patients with fibromyalgia, and were in 
fact similar to that of controls, which suggests that pre-morbid mental health difficulties are not 
inherently linked to fibromyalgia. Differences in distress scores no longer existed after controlling for 
pain threshold and fatigue. They concluded that a history of psychiatric illness may be more related 
to the manner in which healthcare is sought.  
The results of this study have shown that lack of social support, immigration, residence location, family 
history, abuse and post-traumatic stress were all found to be significantly associated with 
fibromyalgia. Cross-sectional and case-control studies cannot make statements about the predictive 
nature of risk factors in the absence of time-related data. Grimes and Schulz60 note that there may be 
a difference in motivation for identifying a cause for illness between cases and controls, which results 
in a higher recall rate for cases. These issues have been considered throughout this review and results 
from these studies have been conceptualised as associations instead of risk factors, to differentiate 
their value in predicting fibromyalgia. The relationship between abuse, PTSD and fibromyalgia has 
been well documented in literature and reviewed elsewhere18,19. A lesser researched area is that of 
the aforementioned social and environmental factors. 
Higher levels of social support are related to more active coping strategies in patients with chronic 
pain61, and larger support networks have been linked to better symptom management in fibromyalgia. 
It is, however, the quality of social support that is associated with lower psychological distress62. This 




this topic, since the quality of social support is more valuable than quantity. Central to this idea is the 
ability to elicit support effectively, in order to be able to successfully use social support networks. Di 
Tella et al.63 demonstrated a negative relationship between alexithymia, distress and the ability to 
employ efficient coping strategies and seek social support in patients with fibromyalgia. Those who 
are unable to articulate their internal world and own needs to others may lead to underutilised social 
support networks, even if they are present and available.  
Previous research has highlighted the significance of socially and behaviourally learned models of pain 
in families64, separate from genetic influences65. Taking a family history is important from this 
perspective because this line of enquiry is typically used in healthcare to ascertain genetic linkage and 
genetic risk, and less so for establishing behavioural and attitudinal baselines around pain conditions.  
Family systems may contribute to the internalisation of bias and stigma surrounding chronic pain66, if 
unhelpful generational and cultural beliefs are being modelled and passed on.   
Studies varied in the method used to ascertain fibromyalgia. Five studies used the ACR-1990 criteria, 
three relied on self-report measures, one used ICD-9 codes and one used the LFESSQ. Two utilised 
medical examination and two relied on medical testing to further verify the presence of fibromyalgia. 
Katz et al.67 demonstrated moderate concordance between use of the ACR-1990, survey, clinical 
methods in ascertaining fibromyalgia, suggesting that, in the absence of a gold standard, the various 
methods are all still valid.  They define fibromyalgia as a ‘trait’ instead of a ‘state’ diagnosis, meaning 
that a person can be considered to have a degree of the condition even if they do not meet all the 
criteria requirements at a certain point in time. Sarzi-Puttini et al.68 theorise that the tenderness 
criteria in the ACR-1990 can be attributed to psychological distress as opposed to pressure pain, which 
raises questions about internal validity. Newer versions of the criteria have been revised (ACR-
2010/2011 and ACR-2016); tender point examination is no longer necessary, and extra consideration 




Because study quality was generally found to be good (based on the ratio of positive to negative 
ratings), the conclusions that can be drawn from this review can be made with greater confidence. 
The prospective cohort design studies were all found to be of appropriate quality in providing a level 
of confidence in their results.  Six studies27,29,32,34–36 recruited from population registries and random 
sampling methods were used to reduce bias. Almost all the studies in this review used logistic 
regression to predict likelihood of fibromyalgia, which is more accurate in the absence of a sampling 
bias.  
4.1. Limitations and Potential Bias 
This review was limited to risk factors identified by published, peer-reviewed studies. Due to 
limitations in time and resources, non-English and unpublished literature was not included. 
Publication bias is therefore a limitation as there will be other studies that demonstrate both 
significant and non-significant results, and exclusion of these studies may overinflate the impact of a 
given risk factor. Participants in the included studies were predominantly Caucasian, with the 
exception of one study which was conducted in Lebanon29, which will limit generalisability to the wider 
population.  
Comments on gender are limited within this review because participants in the included studies were 
predominantly female, with some only recruiting female participants. Obviously, this has significant 
implications for generalising results, but this may be a reflection of problematic historical issues in 
diagnostic criteria. Fibromyalgia is more commonly associated with women6, however, clinical biases 
in the old ACR-1990 diagnostic criteria appear to discriminate against gender. Non-clinical female 
participants have been shown to have a lower threshold for pressure pain across tender point areas70, 
which demonstrates that women are more likely to fulfil criteria according to the ACR-1990. 
Furthermore, research has shown that sociodemographic risk factors for women may not apply to 
men, and women have a longer illness duration51, suggesting that there may be varying illness profiles 




This review specifically focused on fibromyalgia instead of broadening the search to chronic 
widespread pain; some clinicians and academics believe the two conditions overlap to such a degree 
that the validity of the diagnosis is questioned11. It may also be the case that many participants in 
chronic widespread pain research have undiagnosed or misdiagnosed fibromyalgia, thus blurring the 
boundaries in the first instance. This review also restricted the focus to fibromyalgia excluding co-
morbidities (e.g. arthritis), which will limit the generalisability of the results to a less complex 
population. 
Heterogeneity of outcome measures across the included studies limit the strength of the conclusions 
that can be drawn; results were too diverse to synthesise. Meta-analysis was not possible and most 
outcome measures only had one or two studies investigating the same variable. Low education was 
the most commonly studied factor in this review, and due to the varying quality of the results, a 
conservative estimate of effect size was suggested.   
Overall ratings of quality were based on the percentage of positive ratings out of all items available 
for each study. These percentages are broadly equivalent and can be comparable, except for studies 
that rated ‘not applicable’ for certain quality criteria items27–30,35. An arbitrary categorical rating (e.g. 
‘good’ and ‘poor’) was not given to each study because of the heterogenous nature of study design 
and outcomes. Percentages allow for a fairer comparison of bias, however, the limitation with using 
percentages is the assumption that all items are equal in quality and therefore should be given the 
same weight. The percentages stated are therefore arbitrary and are only used to determine which 
studies are qualitatively more biased in comparison to the possible available total score. The second 
reviewer only independently assessed 3 of the included studies, therefore, bias may be present in the 
quality ratings of the remaining 7 studies.  
Two of the included ten studies analysed secondary data28,29. Both of these studies were rated lower 
in quality and this may be a reflection of the study design not being tailor-made for the research 




existing pool of participants. This represents another level of non-randomisation, which may not be 
representative of the wider population and runs the risk of overinflating results. 
4.2. Conclusion 
This review has highlighted some problematic implications for this area of research. There is an 
intrinsic selection bias within the diagnostic criteria for fibromyalgia at the clinical level. Although 
newer versions of the ACR have been proposed to overcome practical limitations and bias against 
gender, many newer empirical studies continue to use the old criteria. Research into risk factors need 
to be based on prospective cohort designs if they are to make valid conclusions about the predictive 
effect of variables. There is problematic heterogeneity across the definition of outcome measures and 
variability across the validated measures used to assess these. Despite these limitations and in the 
context of diverse results, this review has demonstrated that depression, anxiety, childhood adversity, 
work stress and low education are risk factors for the development of fibromyalgia. Lack of social 
support, immigration, urban residence, family history, abuse and post-traumatic stress were all found 
to be significantly associated with fibromyalgia. There will be an element of interrelatedness across 
these variables; research into the moderating and mediating factors will be important to further 
disentangle these relationships. This review sits in line with previous research into the risk factors for 
chronic widespread pain and supports the few existing reviews into the risk factors for fibromyalgia. 
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Objective: Psychological approaches to chronic pain so far have focused on Cognitive Behavioural 
Therapy (CBT) and Acceptance and Commitment Therapy (ACT). There is limited research in 
Compassion-Focused Therapy (CFT) for chronic pain. This study aims to 1) evaluate the suitability of a 
CFT Pain Management Programme (PMP) for adults with chronic pain and 2) explore self-compassion, 
psychological flexibility and psychological inflexibility as potential mediators of improvement in 
outcome. 
Methods: Participants were patients who completed the 11-week PMP at the NHS Lothian Chronic 
Pain Service between February 2018 and March 2019 (n=122). Participants completed the following 
outcome measures at pre-group (week 1), mid-group (week 6) and post-group (week 11): The Brief 
Pain Inventory, Hospital Anxiety and Depression Scale, Self-Compassion Scale, Multi-Dimensional 
Psychological Flexibility Inventory and the Warwick-Edinburgh Mental Wellbeing Scale. One-way 
ANOVAs were used to evaluate the efficacy of the intervention, along with multiple regressions to 
perform mediation analyses. 
Results: Statistically significant improvements were demonstrated in measures of pain interference, 
anxiety, depression, psychological flexibility, psychological inflexibility, self-compassion and mental 
wellbeing by the end of the PMP. The largest improvements were found to occur in the second half of 
the PMP. Self-compassion was shown to mediate improvements in pain interference, whereas 
psychological flexibility and psychological inflexibility were shown to mediate improvements in 
depression and mental wellbeing. Neither predictor variable mediated improvements in anxiety.  
Discussion: This study provides evidence for the use of CFT as a group intervention for chronic pain. 
Psychotherapies already share conceptual overlaps; clinical resources can be better used by 
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1.1. The Impact of Chronic Pain  
Pain is considered to be chronic when it has lasted for longer than 3-6 months, past its primary 
function of nociception1.  A systematic review by Fayaz et al.2 reported the prevalence of chronic pain 
to be between 35.0% and 51.3% across the UK, increasing in prevalence with age and with a greater 
likelihood in women. In 1998, the socio-economic costs of back pain in the UK were estimated to be 
£1.6 billion, taking into account healthcare usage, production losses and informal carers3. Evidently, 
chronic pain is a major health issue for both the individual and the wider systems around the 
individual. Research shows that chronic pain has an extensive, negative impact on physical health, 
psychological wellbeing, daily functioning, relationships and occupation4,5. 
In the process of learning to live with chronic pain, sufferers may have experiences of being disbelieved 
by family, friends and health professionals, struggle with their own beliefs of being a burden on their 
loved ones and feel disappointment at perceived inability to fulfil previously held roles in the family 
and workplace6,7. Chronic pain can become stigmatic through the internalisation of such experiences8, 
and in conjunction with debilitating physical symptoms, it has a profound impact on the sense of self. 
The intensity of the pain is often not the main issue9; interpretations of pain can perpetuate distress, 
for example, in the negative beliefs and learned associations that someone may hold about their 
pain10. Because negative cognitions and emotions are activated by pain-related difficulties, multi-
disciplinary treatments for chronic pain seek to manage these internal experiences and modify 






1.2. Current Treatment Models in Chronic Pain: CBT 
Alongside education and physical exercise, Cognitive Behaviour Therapy (CBT) and Acceptance and 
Commitment Therapy (ACT) are used across multidisciplinary pain management programmes in the 
treatment of chronic pain (as described in SIGN Guideline 13611). 
CBT for chronic pain uses the biopsychosocial model to identify and address the distressing appraisals, 
distorted cognitions and maladaptive behaviours that exacerbate pain. Techniques such as graded 
activation and exposure are used to help achieve sustainable levels of activity and reduce 
avoidance12,13. A Cochrane review in 201213 involving 42 studies reported small effects on disability 
and catastrophising in comparison to active controls. No such effect was found on pain or mood. 
Moderate effects on pain disability, mood and catastrophising were found when compared to wait list 
controls, however, the use of wait list controls exaggerate apparent efficacies14, with a danger of 
overstating the evidence base for CBT for chronic pain. There was evidence to suggest that gains in 
mood and catastrophising were maintained at six months post-treatment. The authors concluded that 
further randomised controlled trials reporting on mean treatment group differences will not lead to 
scientific or clinical progress, and instead, research should focus on how CBT works.  
The philosophy of randomised controlled trials does not translate well into psychotherapy research 
because it is difficult to isolate an active component15. Psychotherapies share commonalities such as 
therapeutic relationships, collaboration and acceptance of psychological and cultural explanations of 
distress16, and even tightly controlled trials face difficulties with generalisation because of unrealistic 
exclusion criteria and fidelity to treatments15. Gaudiano17 notes that more attention should be focused 
on the mechanisms of action as opposed to pitting separate treatments against each other and 
drawing conclusions about their efficacy based on differences across outcomes. 
Turner et al.18 identified key mediators behind the effects of CBT: change in pain beliefs, 




disability at one year. Change in pain beliefs was found to be the mediator with the greatest effect on 
outcomes of pain and activity interference, although there was a degree of relatedness between the 
mediators. Self-efficacy was found to be independent of the other process variables. Pain 
catastrophising was also identified as a mediator in similar studies19,20, as was internal locus of pain 
control19. From these results, it is clear that the active ingredients in CBT are processes that are not 
unique to CBT21; such therapeutic targets are of interest in other psychological therapies, although the 
components may be conceptualised from a different perspective. 
1.3. Current Treatment Models in Chronic Pain: ACT, Psychological Flexibility and 
Psychological Inflexibility 
ACT aims to help people move towards valued behaviour and increase willingness to accept and 
tolerate undesirable internal experiences. Unlike CBT, ACT does not attempt to alter the content of 
negative cognitions; instead, the focus is to manage responses and make behavioural adjustments in 
a manner that is consistent with a person’s values. This lessens the influence of behaviour that is 
driven by pain-related avoidance, which contributes to disability. A systematic review by Hughes et 
al.22 examined 11 trials of ACT for adults with chronic pain, finding significant medium to large effect 
sizes for measures of acceptance and psychological flexibility, although this was mainly in comparison 
to treatment as usual controls. Another review by Veehof et al.23 included 22 studies and reported 
medium effect sizes of ACT and mindfulness-based treatments on pain intensity, mood, physical 
wellbeing and quality of life. The authors question the validity of using pain intensity as an outcome 
measure when neither ACT nor CBT focus on reducing pain intensity. They recommend that future 
studies include other pain measures, such as pain interference.  
The key elements of ACT are psychological flexibility and inflexibility24. Psychological flexibility can be 
defined as adaptable responses to negative internal and external events, which promote wellbeing; 




events, which are associated with psychological distress25. Cross-sectional evidence demonstrates that 
psychological inflexibility is linked to anxiety, depression and wellbeing26. The six-factor theory of 
psychological flexibility (the Hexaflex model27) is made up of six components: contact with the present 
moment, values, committed action, self as context, defusion and acceptance25. The six-factor theory 
of psychological inflexibility is made up of six further components: lack of contact with the present 
moment, lack of contact with values, inaction, self-as-context, fusion and experiential avoidance25. 
 Vowles et al.28 performed correlation and regression analyses and reported significant relationships 
between all aspects of psychological flexibility and measures of disability, emotional functioning, pain 
acceptance and valued activity. Four key process variables of psychological flexibility were 
investigated by McCracken and Gutierrez-Martinez29: pain acceptance, values-based action, 
psychological acceptance and mindfulness. General acceptance was found to show the largest effect 
size, predicting gains in outcome more so than those accounted for by pain acceptance. Psychological 
flexibility was also shown to moderate outcomes of pain interference on an internet-based ACT for 
chronic pain30. In summary, psychological flexibility and inflexibility appear to be a highly relevant 
processes in understanding and influencing responding to chronic pain, leading to improved function 
across a range of parameters.  
1.4. CFT and Self-Compassion 
Compassion-Focused Therapy (CFT) was developed for individuals who struggle with shame and self-
criticism31, both of which can be conceptualised as examples of distressing private experiences in the 
ACT model. It aims to promote a compassionate relationship with the self, drawing on the ability to 
view distressing experiences with kindness, understanding and shared humanity32. Shame involves a 
negative evaluation of the self, unlike guilt, which involves a negative evaluation of behaviour33. This 
is especially relevant in chronic pain, where people are faced with pervasive internal and external 




analysis and is centred around emotion regulation via the three circles model: the threat (fight or 
flight), drive (resource-seeking) and soothe (nurturing attachment) systems. From this perspective, an 
impoverished soothe system results in emotional dysregulation and CFT asserts that increasing self-
compassion is fundamental to reassurance, safety and wellbeing31. A systematic review in 201434 
included 14 studies of CFT, showing favourable results for mood disorders and for those high in self-
criticism. The evidence was insufficient, however, to show that CFT was superior to other approaches 
such as CBT, although using CFT jointly with CBT increased efficacy. No studies in the review explored 
self-compassion as a mediator in the relationship between intervention and outcome.  
The positive influence of self-compassion has already been investigated across a range of long-term 
health conditions, such as diabetes35 and cancer36. Wren et al.37 found self-compassion to be a 
significant predictor of mood, negative pain beliefs and disability related to pain. This cross-sectional 
study indicated that self-compassion may be significant in predicting pain adjustment, but can only 
comment on association and not causal relationships. The authors suggest that future research in this 
area could examine interventions specifically designed to promote self-compassion. Marshall and 
Brockman38 reported self-compassion to significantly correlate with processes of psychological 
flexibility, and self-compassion actually predicted mental wellbeing over and above psychological 
flexibility. This indicates that combining these therapies may result in improved treatment outcomes. 
This study was, however, conducted on a non-clinical population which may limit generalisability. 
Empirical research examining links between these two constructs is limited.  
A recent exploratory study by Penlington39 evaluated a compassion-focused group for chronic pain 
within a routine clinical setting. This was an 8-week programme of mindfulness and loving-kindness 
exercises, showing small to moderate effect sizes of improvements in pain distress and depression, 
and moderate to large effect sizes of improvements in anxiety. Small improvements were found in 
measures of pain intensity and self-efficacy. Although lacking in internal validity, as an exploratory 




recruitment. Other smaller studies have derived similar results for compassion cultivation for chronic 
pain40 and for loving-kindness meditation for chronic low back pain41. 
The previous sections have been segregated by therapeutic orientation for the purpose of structure 
and clarity, but there is clearly a large degree of commonality between concepts and constructs. Self-
acceptance can be easily conceptualised as self-kindness. Acts of psychological inflexibility, such as 
avoiding negative experiences and fusing with harmful narratives, are really acts of self-rejection and 
self-criticism. Conversely, acts of psychological flexibility, embracing and being open to all parts of the 
self and choosing actions based on personal integrity, these are inherently kind, supportive and self-
validating acts. The evidence base reflects these conceptual overlaps and, furthermore, suggest that 
ACT and CFT can be integrated for maximum clinical benefit.  
1.5. Rationale  
There is a need for evidence-based answers to explain why and how psychological interventions are 
successful42. Randomised controlled trials are inadequate for comparing models and multi-modal 
treatments cannot separate the contribution of different principles. For example, comparisons 
between an ACT and a CBT pain management programme showed no differences in improvements in 
pain interference, depression, anxiety and quality of life43. Designing trials to isolate the influence of 
different principles would be expensive and time-consuming; a different strategy is to test mediation 
hypotheses. CFT offers a complementary approach to be used alongside current interventions, 
targeting the frequent feelings of shame and self-criticism in the process of adjusting to chronic pain. 
Research suggests that there is theoretical basis for the use of CFT in chronic pain, and a strong 
correlation between self-compassion and psychological flexibility has already been established. 
Gaining insight into the direction of these relationships and using these concepts to optimise 




1.6. Study Hypotheses 
1. An 11-week Compassion-Focused Therapy Pain Management Programme (PMP) group 
intervention will significantly improve measures of pain interference, anxiety, depression, 
psychological flexibility, self-compassion and psychological wellbeing. 
2. Self-Compassion, Psychological Flexibility and Psychological Inflexibility will mediate the 
improvements in pain interference, anxiety, depression and psychological wellbeing from 
Week 1 to Week 11. 
2. Methodology 
2.1. Participants 
Participants were adults with chronic pain who attended a PMP at the NHS Lothian Chronic Pain 
Service between February 2018 and March 2019. This centralised outpatient service is located in 
Edinburgh, receiving referrals mainly from General Practitioners, a multidisciplinary pain clinic and 
secondary care consultants. Potential PMP patients were assessed for suitability by the clinical team 
(Clinical/Counselling Psychologists and Physiotherapists) during a routine one-to-one assessment 
upon referral to the Chronic Pain Service. Patients were eligible for the current study if they were over 
the age of 18, suffered from chronic pain lasting a minimum of three months, and were of adequate 
English fluency, sufficient for participation in a group. Patients were not eligible for the study if they 
were unable to provide consent (as defined by the Five Statutory Principles of the Mental Capacity 
Act44). If a patient was deemed to be suitable for a PMP, an introductory group session was offered, 
followed by invitation to an upcoming 11-week PMP. Participants were briefed about the study during 
the first week of the PMP, with questionnaires and consent forms to be completed and returned the 
following week if consent was given. Figure 2 depicts the journey of a PMP patient through the service 




Figure 2 Participant flow through PMP and recruitment for research 
 
  
Patient is referred to the NHS Lothian Chronic Pain 
Service
Patient invited to 1-1 assessment with a qualified 
Psychologist or Physiotherapist (T0)
• Routine assessment questionnaires are collected at this 
appointment
If suitable for a PMP, patient is offered a once-off 
introductory group session 
Patient invited to Week 1 of PMP (T1)
• Patients are briefed about the current study and given 
information sheets, consent forms and pre-group questionnaires, 
to be collected next week if patient gives consent
Mid-group questionnaires collected at Week 6 of 
PMP (T2)





2.2. Power and Sample Size 
Fritz and MacKinnon45 propose guidelines for recommended sample sizes in order to detect mediation 
effects, informed by existing literature. Research into self-compassion and chronic pain is currently 
limited, therefore, sample size calculations were based on correlations between pain interference and 
psychological flexibility (r values between 0.37 and 0.4646). Other findings of relevance include 
correlations between psychological flexibility and outcomes of group interventions for chronic pain (r 
values between 0.33 and 0.5529) and between psychological flexibility and psychological functioning 
(r values between -0.47 and -0.5147). Hayes et al.27 conducted a meta-analysis on the correlations 
between measures of psychological flexibility and psychopathology, with the vast majority of the 
included studies demonstrating large effect sizes between psychological flexibility and anxiety, 
depression and quality of life measures. Since the literature demonstrates medium to large 
correlational sizes across the α and β pathways of the mediation model, it was determined that a 
sample size of 53-71 participants would be required to detect an effect with .8 power.  
2.3. Procedure 
A small subset of the questionnaires was collected at assessment (T0), prior to starting the PMP; this 
was the waiting list period. Over the course of the PMP, five outcome measures were collected at 
three timepoints: pre-group (T1), mid-group (T2) and post-group (T3) (see Figure 2). Information sheets, 
consent forms and pre-group measures (Appendix 6-8) were given out at the start of the group (week 
1), to be completed and returned the following week; participants were given a full week to consider 
their voluntary involvement in the research. Mid-group measures were collected at week 6 and post-
group measures were collected at week 11. Those who did not give consent were asked to complete 
the outcome measures at week 1 and week 11, as the service routinely collects the same information 




2.4. Outcome Measures 
2.4.1. Pain 
The Brief Pain Inventory (short form, BPI-SF48) is an 11-item measure designed to capture two aspects 
of pain: pain interference with daily living (e.g. “relations with other people”) and pain severity (e.g. 
“at its worst in the last 24 hours”. These two distinct dimensions have been confirmed through factor 
analysis. Responses to items on this measure range from 0 (does not interfere) to 10 (completely 
interferes) on the pain interference subscale and 0 (no pain) to 10 (pain as bad as you can imagine) on 
the pain severity subscale. The BPI-SF shows stable test-retest reliability and high internal consistency, 
with Cronbach’s α ranging from .80 to .9249. In this sample, the pain intensity subscale showed high 
internal consistency (Cronbach’s α = .86/.92/.92 for pre/mid/post timepoints); and the pain 
interference subscale also showed high internal consistency (Cronbach’s α = .87/.93/.91 for 
pre/mid/post timepoints). The Initiative on Methods, Measurement, and Pain Assessment in Clinical 
Trials (IMMPACT50) recommends that all chronic pain research should include outcomes in pain 
interference and pain severity. 
2.4.2. Anxiety and Depression 
The Hospital Anxiety and Depression Scale (HADS)51 is a 14-item measure of the symptoms of anxiety 
(7 items) and depression (7 items) in individuals with physical health issues. Each of the items are 
scored from 0 to 3, where a higher score depicts greater frequency or intensity of the described 
symptom over the last week (e.g. “I get sudden feelings of panic” and “I have lost interest in my 
appearance”). Anxiety and depression are rated separately, each allowing for a minimum score of 0 
or a maximum score of 21. Bjelland et al.52 reviewed 747 papers using the HADS and demonstrated a 
two-factor structure (i.e. anxiety and depression), with a high level of internal consistency for both the 
anxiety (Cronbach’s α = .83) and depression (Cronbach’s α = .82) subscales. In this sample, the anxiety 




and the depression subscale also showed high internal consistency (Cronbach’s α = .82/.85/.82 for 
pre/mid/post timepoints). Michopoulos and authors (2008)53 demonstrated a high test-retest 
reliability of .94 over a 20-day period.   
2.4.3. Psychological Flexibility and Inflexibility 
The Multi-Dimensional Psychological Flexibility Inventory (short form, MPFI-SF25) is a 24-item measure 
assessing openness to negative experiences such as thoughts and feelings (psychological flexibility) 
and fixed ways of reacting to negative experiences (psychological inflexibility). 12 items measure 
psychological flexibility and 12 items measure psychological inflexibility. The MPFI aims to measure all 
the components of the Hexaflex model, and has been shown to demonstrate both discriminant and 
convergence validity25. Response to items range from 0 (never true) to 6 (always true) of items in the 
context of the last two weeks (e.g. “I stuck to my deeper priorities in life” and “negative feelings often 
trapped me in inaction”). The MPFI demonstrates an excellent level of internal consistency for both 
the flexibility and inflexibility subscales (Cronbach’s α = .88 to .91 across a range of demographic 
groups)25. In this sample, the flexibility subscale showed good internal consistency (Cronbach’s α = 
.78/.93/.94 for pre/mid/post timepoints); and the inflexibility subscale also showed good internal 
consistency (Cronbach’s α = .70/.87/.87 for pre/mid/post timepoints). This supersedes the levels of 
internal consistency found for the Acceptance and Action Questionnaire27, the Acceptance and Action 
Questionnaire–II54 and the Avoidance and Fusion Questionnaire55, which are the most common tools 
used in this area25. 
2.4.4. Self-Compassion 
The Self-Compassion Scale (short form, SCS-SF32) is a 12-item measure designed to assess a person’s 
kindness and understanding towards themselves during difficult times. Responses to these items (e.g. 
“I try to see my failings as part of the human condition”) are indicated on a Likert scale, ranging from 




and factor analysis has validated the six-factor model, in addition to the single higher-order factor of 
self-compassion56. The SCS-SF shows high internal consistency (Cronbach’s α = .8656) and good test-
retest reliability over three weeks (scores of at least .8 across all subscales)32. In this sample, the SCS-
SF showed good internal consistency (Cronbach’s α = .85/.86/.72 for pre/mid/post timepoints).  
2.4.5. Mental Wellbeing 
The short-form Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS57) is a 7-item measure 
reporting on subjective positive mental wellbeing and psychological functioning over the last two 
weeks, validated for use in a British adult population. It aims to cover a broad range of positive mental 
health concepts (e.g. “I’ve been feeling useful” and “I’ve been feeling close to other people”) but does 
not include spirituality or socioeconomic factors. Each of the items on the measure require a response 
on a Likert scale, from 1 (none of the time) to 5 (all of the time). This yields a minimum score of 7 and 
a maximum score of 35. The SWEMWBS has a good level of internal consistency (Cronbach’s α = .84 
in Norway and .86 in Sweden58). In this sample, the SWEMWBS showed high internal consistency 
(Cronbach’s α = .83/.88/.91 for pre/mid/post timepoints). There is no information available on test-
retest reliability (according to its website https://www.corc.uk.net/outcome-experience-
measures/short-warwick-edinburgh-mental-wellbeing-scale), however, the long-form WEMWBS’s 
test-retest reliability of .83 demonstrated stability after one week57. 
2.5. Intervention 
The group intervention took place over 11 consecutive weeks, 3 hours per session. Week 6 and Week 
11 were individual one-to-one sessions, with one of the two group facilitators. Two to three groups 
started each month, with 6 groups (at different stages) running each week. Groups were booked to 
17 patients per group and were facilitated by a qualified Psychologist and Physiotherapist. Psychology 
facilitators participated in four days’ CFT training facilitated by Dr Chris Irons, Clinical Psychologist, 




the 11-week group intervention. Participants were given workbooks and clinicians referred to slides 
and session notes throughout the group. All psychology facilitators received regular individual and 
group supervision from qualified Clinical Psychologists working in the service.  
2.6. Ethics 
Ethical approval was sought through the NHS Integrated Research Approval Service and a Research 
Ethics Committee granted approval on 9th February 2018. (REC reference 17/EM/0465) (Appendix 4). 
This included review of participant information sheets, consent forms and outcome measures 
(Appendix 6-8). 
 
Table 3 Session content of the CFT group per week 
Week Session Content 
1 Introduction and group guidelines; pain education; adjustment 
2 Movement and pacing; introduction to CFT: tricky brain 
3 Three circles model of CFT; pacing; pain, stress and coping  
4 Goals; compassion and mindfulness 
5 Compassionate thoughts; sleep hygiene 
6 Individual review with a group facilitator 
7 Pain and relationships (a friend or family member can attend this week); flare-up planning 
8 Functional movement; compassionate imagery (other); endings 
9 Compassion and adjustment; compassionate imagery (self) 
10 Maintaining progress; compassionate letter writing 
11 Individual review with a group facilitator 







2.7. Statistical Analyses 
Analyses were completed using SPSS 24. Missing data for those who did not complete the PMP was 
imputed using last observation carried forward (LOCF). Little’s Missing Completely at Random (MCAR) 
test indicated that the data was missing at random: χ2 (475, N = 122) = 317.402, p = 1.000. Missing 
data across individual questionnaires (i.e. unanswered questions on completed questionnaires) was 
imputed using Expectation Maximisation (EM), where missing data was <10% and normally 
distributed. The percentage of missing data across individual questionnaires varied from 0.8% to 8.2%, 
with a few exceptions: 14.8% of data was missing across assessment (T0) questionnaires, missing data 
from pre-group (T1) psychological flexibility (MPFI) was 22.1% and missing data from mid-group (T2) 
psychological flexibility (MPFI) 17.2%. Listwise deletion was employed where EM was not appropriate. 
This was deemed to be a suitable alternative since data was missing at random and the sample size 
was large enough to remain adequately powered, as recommended by Cheema59. 
Assumptions of normality were met since skewness was found to be between -0.842 and 0.624 across 
all levels of the outcome measures at each timepoint; and kurtosis was between -0.858 and 0.556. 
These values are between the minimum and maximum allowable values of -1.00 and 1.00 for an 
ANOVA and regression60. A one-way ANOVA was used on participant demographics and completion 
status (full completers, mid-completers and non-completers), and on pre-group outcome measures 
across different levels of completion status, in order to test the equivalence of completers versus non-
completers. Appropriate corrections were used where Mauchly’s Test of Sphericity was violated 
(Greenhouse-Geisser when ε < 0.75 and Huynh-Feldt when ε > 0.75). A repeated measures ANOVA 
with post-hoc Bonferroni corrections was used on the assessment, pre-, mid- and end-group outcome 
measures to test the efficacy of the PMP. 
Mediation analyses were performed using guidelines recommended by Judd, Kenny and McClelland61 




of standard residuals highlighted two outliers, which were removed. Following this, all assumptions 
were met.  
3. Results 
Out of the 122 participants, 18 (14.7%) dropped out of the intervention before the mid-point and 14 
(11.5%) dropped out of the intervention after the mid-point. In total, 32 participants did not complete 
the PMP (an attrition rate of 26.2%). No significant differences were found across participant 
demographics and completion status (Table 4). No significant differences were found between scores 
of pain intensity, pain interference, anxiety or depression between assessment (T0) and pre-group (T1) 
(Table 5), nor across pre-group outcome measures at different levels of completion status (Table 6). 
The repeated measures ANOVA showed significant improvement in measures of pain interference, 
anxiety, depression, psychological flexibility, psychological inflexibility, self-compassion and mental 
wellbeing by the end of the PMP (Table 7). There was no significant difference in scores of pain 
intensity by the end of the group.  
The average level of anxiety moved from the ‘moderate’ range to the ‘mild’ range by the end of the 
PMP, according to clinical cut-off scores on the HADS51, whilst depression remained in the ‘mild’ range. 
Those who did not complete the PMP scored an average of ‘moderate’ depression at pre-group, 
whereas those who completed the PMP scored an average of ‘mild’ depression at pre-group, although 
this distinction was not deemed to be statistically significant. The average score of self-compassion 
was in the ‘moderate’ range32 before the PMP started, and remained in this range by the end of the 






Table 4 Participant demographics and significance levels by completion status 
    Completer (n=90) Non-Completer (n=32) p 
Gender   0.279 
 Female 74 (82.2%) 29 (90.6%)  
 Male 16 (17.8%) 3 (9.4%)  
Age      0.274 
 16-24 1 (1.1%) 1 (3.1%)  
 25-34 13 (14.4%) 6 (18.8%)  
 35-44 23 (25.6%) 9 (28.1%)  
 45-54 24 (26.7%) 10 (31.3%)  
 55-64 24 (26.7%) 3 (9.4%)  
 65-74 4 (4.4%) 3 (9.4%)  
  75-84 1 (1.1%) –  
Duration of pain    0.755 
 <1 year 5 (5.6%) –  
 12-17 months 5 (5.6%) 1 (3.1%)  
 18-24 months 2 (2.2%) 2 (6.3%)  
 2-3 years 5 (5.6%) 2 (6.3%)  
 4-5 years 9 (10.0%) 3 (9.4%)  
 6-10 years 17 (18.9%) 7 (21.9%)  
 11-20 years 17 (18.9%) 6 (18.8%)  
 21+ years 9 (10.0%) 2 (6.3%)  
 Missing 21 (23.3%) 9 (28.1%)  
Diagnosis    0.560 
 Back Pain 33 (36.7%) 9 (28.1%)  
 Fibromyalgia 25 (27.8%) 8 (25.0%)  
 ME/Chronic Fatigue 3 (3.3%) 1 (3.1%)  
 Arthritis 3 (3.3%) 1 (3.1%)  
 CRPS 2 (2.2%) 1 (3.1%)  
 IBS/Abdominal 2 (2.2%) –  
 Headache/Facial 2 (2.2%) 2 (6.3%)  
 No Diagnosis 2 (2.2%) 2 (6.3%)  
 Other 7 (7.8%) 2 (6.3%)  
  Missing 11 (12.2%) 6 (18.8%)  
Employment    0.452 
 Full-time 21 (23.3%) 5 (15.6%)  
 Part-time 14 (15.6%) 5 (15.6%)  
 Voluntary 2 (2.2%) 1 (3.1%)  
 Not working due to pain 24 (26.7%) 11 (34.4%)  
 Not working for other reason 7 (7.8%) 2 (6.3%)  






Table 5 Comparison of study variables between assessment (T0) and pre-group (T1) 
Outcomes (n=92)     Means (SD)    
  Assessment (T0) Pre-Group (T1)  F p ηp
2 
BPI        
 Pain Intensity
SA 24.34 (6.48) 24.46 (5.69)  0.046 0.830 0.001 
 Pain Interference
SA 49.44 (13.44) 48.91 (11.00)  0.249 0.619 0.003 
HADS       
 Anxiety
SA 12.00 (4.79) 12.14 (4.22)  0.140 0.709 0.002 
 Depression







Table 6 Comparison of study variables at pre-group between completers, mid-completers and non-completers 
Pre-group Outcomes  Means (SD)   
 Full Completer Mid-Completer Non-Completer p 
BPI      
 Pain Intensity 24.59 (6.07) 26.93 (5.61) 23.06 (4.62) 0.187 
 Pain Interference 50.44 (10.90) 52.07 (12.02) 45.22 (13.56) 0.161 
HADS      
 Anxiety 12.23 (4.37) 13.21 (3.96) 12.70 (3.27) 0.684 
 Depression 10.62 (3.79) 12.36 (3.15) 11.72 (2.99) 0.162 












SCS      
 Self-Compassion 29.85 (8.13) 26.80 (10.10) 28.60 (8.23) 0.418 
WEMWBS     








Table 7 Comparison of study variables at pre-group, mid-group and post-group 
Outcomes (n=89)     Means (SD)    
  Pre-Group Mid-Group End-Group F p ηp
2 
BPI        
 Pain Intensity
SA 24.66 (6.26) 24.30 (6.75) 24.66 (6.26) 1.277 0.281 0.014* 
 Pain Interference
GG 48.87 (12.10) 45.87 (41.02) 42.26 (13.67) 22.088 <0.001 0.201* 
HADS       
 Anxiety
HF 12.32 (4.13) 11.42 (4.34) 10.26 (4.44) 18.876 <0.001 0.177* 
 Depression
HF 10.76 (3.55) 10.20 (3.82) 9.00 (4.20) 18.032 <0.001 0.170* 
MPFI       
 Psych Flexibility
HF 39.21 (10.74) 41.48 (10.61) 43.00 (9.83) 9.391 <0.001 0.096* 
 Psych InflexibilitySA 41.06 (9.19) 41.06 (9.19) 37.45 (8.70) 20.686 <0.001 0.190* 
SCS       
 Self-Compassion
GG 30.10 (8.04) 30.99 (8.61) 33.39 (9.26) 16.103 <0.001 0.155* 
WEMWBS       
 Mental Wellbeing
HF 18.73 (4.17) 20.13 (4.48) 21.95 (5.04) 35.976 <0.001 0.290** 
SASphericity assumed; GGGreenhouse-Geisser correction where ε < 0.75; HFHuynh-Feldt correction where ε > 0.75 






Table 8 Post-hoc comparisons of mean differences of study variables between timepoints 
Outcomes (n=89) Mean Difference T1 - T2 Mean Difference T2 - T3 
   Δx̅ p ηp
2 Δx̅ p ηp2 
BPI         
 Pain Intensity 0.36 0.261 0.014* -0.36 0.261 0.014* 
 Pain Interference 3.00 0.001 0.112* 3.61 <0.001 0.141* 
HADS         
 Anxiety  0.90 0.004 0.091* 1.16 <0.001 0.139* 
 Depression 0.56 0.048 0.044* 1.20 <0.001 0.192* 
















SCS         
 Self-Compassion 0.89 0.033 0.051* 2.40 <0.001 0.146* 
WEMWBS        
 Mental Wellbeing 1.40 <0.001 0.142* 1.82 <0.001 0.257** 






Post-hoc analyses compared the changes in outcome between the first and second half of the group 
(Table 8). The analysis showed that the largest improvements occurred in the second half of the group 
(T2 - T3) across all outcome measures, with the exception of pain intensity and psychological flexibility. 
Psychological flexibility was the only measure to show a lesser effect size in the second half of the 
group. Interestingly, there was no noticeable difference between means of psychological inflexibility 
from pre-group to mid-group. Mental wellbeing demonstrated a large effect size in both halves of the 
PMP. Self-compassion was the outcome with the largest difference in effect size between the first and 
second halves of the group.  
3.1. Mediation Analyses  
Mediation analyses were performed to explore the hypothesis that changes in psychological flexibility, 
psychological inflexibility and self-compassion (the predictor variables) mediate the difference in pain 
interference, anxiety, depression and mental wellbeing (the dependent variables) from pre-group to 
post-group. According to Judd et al.’s61 recommendations, an effect of mediation is indicated under 
the following conditions: 1) the predictor and dependent variables both significantly change between 
timepoints (i.e. between T1 and T3, as previously confirmed in Tables 7 and 8); 2) the predictor variable 
predicts the dependent variable at each timepoint (at T1 and T3); and 3) the difference of the predictor 
variable (T1-T3) predicts the difference of the dependent variable. An effect of moderation, however, 
is indicated if the sum of the predictor variable (T1+T3) predicts the difference of the dependent 
variable. This last analysis was included to ensure that the effect is one of mediation, not moderation.  
As seen in Table 9, self-compassion predicted pain interference at pre-group (β = 0.305, p = 0.013) and 
post-group (β = 0.321, p = 0.004). The mean difference in self-compassion significantly predicted the 
mean difference in pain interference (β = 0.263, p = 0.014). This shows mediation of the treatment 
effect on pain interference by self-compassion.  The mean sum of self-compassion did not significantly 
predict the mean differences in pain interference, which shows that self-compassion is not a 




inflexibility was found to predict pain interference at pre-group (β = 0.266, p = 0.017), but not at post-
group (β = 0.204, p = 0.054), and was therefore not a mediator of the treatment effect on pain 
interference from pre-group to post-group. 
Psychological inflexibility predicted anxiety at pre-group (β = 0.461, p < 0.001) at post-group (β = 0.427, 
p < 0.001) (Table 10). The mean difference in psychological inflexibility, however, did not predict the 
mean difference in anxiety (β = 0.157, p = 0.131). This shows no mediation of the treatment effect on 
anxiety by psychological inflexibility. Results were non-significant for the other predictor variables at 
both timepoints, except for self-compassion, which was shown to predict post-group anxiety (β = 
0.282, p = 0.003). None of the predictor variables were found to mediate or moderate the difference 
in anxiety from pre-group to post-group.  
Psychological flexibility, psychological inflexibility and self-compassion predicted depression at pre-
group (β = 0.290, p = 0.008; β = 0.271, p = 0.005; β = 0.225, p = 0.031) and post-group (β = 0.238, p = 
0.015; β = 0.235, p = 0.016; β = 0.251, p = 0.013) (Table 11). Only the mean difference in psychological 
flexibility and psychological inflexibility significantly predicted the mean difference in depression (β = 
0.249, p = 0.013; β = 0.346, p = 0.001). This shows mediation of the treatment effect on depression by 
psychological flexibility and inflexibility, but not self-compassion (β = 0.144, p = 0.124).  The mean 
sums of psychological flexibility and psychological inflexibility did not significantly predict the mean 
difference in depression, which shows that psychological flexibility and psychological inflexibility are 
not moderators on the difference in depression from pre-group to post-group.  
Psychological flexibility and inflexibility predicted mental wellbeing at pre-group (β = 0.412, p < 0.001; 
β = 0.240, p = 0.005) and post-group (β = 0.482, p < 0.001; β = 0.192, p = 0.024) (Table 12). The mean 
difference in both psychological flexibility and psychological inflexibility significantly predicted the 
mean difference in depression (β = 0.421, p < 0.001; β = 0.306, p = 0.001). This shows mediation of the 
treatment effect on mental wellbeing by psychological flexibility and psychological inflexibility.  The 




mean difference in mental wellbeing, which shows that psychological flexibility and psychological 
inflexibility are not moderators on the difference in mental wellbeing from pre-group to post-group. 
Self-compassion was found to predict mental wellbeing at pre-group (β = 0.228, p = 0.015), but not at 
post-group (β = 0.161, p = 0.066), and was therefore not a mediator of the treatment effect on mental 
wellbeing from pre-group to post-group.  
4. Discussion   
The results of this study demonstrated that a CFT PMP significantly improved measures of distress and 
disability related to chronic pain in adults. After 11 weeks, there was improvement across scores of 
pain interference, anxiety, depression, psychological flexibility, psychological inflexibility, self-
compassion and mental wellbeing. These improvements are demonstrative of small effect sizes, with 
the exception of mental wellbeing, which improved with moderate effect size (according to guidelines 
by Cohen63). There was no significant difference in scores of pain intensity, which is not surprising as 
PMPs do not seek to target pain intensity as a primary objective. These results are in line with current 
early research on the benefits of compassion interventions for chronic pain39–41. Unfortunately, no 
follow-up was conducted during this study; one other study in this area reported maintained gains at 
3 months41.  
The second finding of this study was that the biggest change occurred in the second half of the PMP 
(although statistically significant improvements were found even at mid-point). This was true of all 
measured domains, excluding psychological flexibility and psychological inflexibility. Psychological 
flexibility was the only measure to show a lesser effect size in the second half of the group and, 
interestingly, there was no noticeable difference between means of psychological inflexibility from 
pre-group to mid-group. Perhaps this is not a surprising result in the context of a CFT intervention, 
where there is no explicit reference to psychological flexibility or inflexibility. These larger effect sizes 
in the second half of the PMP is of clinical significance in the NHS, where there is increasing pressure 




Table 9 Mediation analyses for psychological flexibility (MPFI), psychological inflexibility (MPFI) and self-compassion (SCS) on pain interference 
            Standardised β Coefficients 
Dependent Variable Predictor R2 F p   β t  p (β) 95% CI 
          
T1 Pain Interference T1 Psychological Flexibility 0.190 6.802 <0.001  -0.070 -0.567 0.572 -0.335, 0.187 
 T1 Psychological Inflexibility      0.266 2.424 0.017 0.060, 0.602 
 T1 Self-Compassion     0.305 2.548 0.013 0.095, 0.771 
          
T3 Pain Interference T3 Psychological Flexibility 0.266 14.005 <0.001  0.062 0.588 0.558 -0.195, 0.359 
 T3 Psychological Inflexibility     0.204 1.945 0.054 -0.006, 0.602 
 T3 Self-Compassion      0.321 2.949 0.004 0.155, 0.786 
          
T1-T3 Pain Interference T1-T3 Psychological Flexibility 0.123 4.062 0.009  0.135 1.120 0.230 -0.100, 0.413 
 T1-T3 Psychological Inflexibility     0.057 0.516 0.607 -0.226, 0.385 
 T1-T3 Self-Compassion     0.263 2.502 0.014 0.083, 0.726 
          
T1+T3 Pain Interference T1+T3 Psychological Flexibility 0.016 0.457 0.713  -0.098 -0.684 0.496 -0.214, 0.105 
 T1+T3 Psychological Inflexibility     -0.019 -0.148 0.883 -0.714, 0.150 






Table 10 Mediation analyses for psychological flexibility (MPFI), psychological inflexibility (MPFI) and self-compassion (SCS) on anxiety 
            Standardised β Coefficients 
Dependent Variable Predictor R2 F p   β t  p (β) 95% CI 
          
T1 Anxiety T1 Psychological Flexibility 0.612 17.530 <0.001  0.116 1.028 0.293 -0.039, 0.128 
 T1 Psychological Inflexibility      0.461 4.771 <0.001 0.123, 0.298 
 T1 Self-Compassion     0.151 1.431 0.156 -0.031, 0.188 
          
T3 Anxiety T3 Psychological Flexibility 0.473 34.732 <0.001  0.074 0.833 0.407 -0.047, 0.114 
 T3 Psychological Inflexibility     0.427 4.797 <0.001 0.125, 0.301 
 T3 Self-Compassion      0.282 3.058 0.003 0.050, 0.233 
          
T1-T3 Anxiety T1-T3 Psychological Flexibility 0.466 8.142 <0.001  0.319 3.038 0.003 0.045, 0.217 
 T1-T3 Psychological Inflexibility     0.157 1.522 0.131 -0.024, 0.179 
 T1-T3 Self-Compassion     0.137 1.385 0.169 -0.032, 0.182 
          
T1+T3 Anxiety T1+T3 Psychological Flexibility 0.094 0.261 0.853  -0.004 -0.031 0.976 -0.056, 0.055 
 T1+T3 Psychological Inflexibility     -0.063 -0.485 0.629 -0.071, 0.043 







Table 11 Mediation analyses for psychological flexibility (MPFI), psychological inflexibility (MPFI) and self-compassion (SCS) on depression 
            Standardised β Coefficients 
Dependent Variable Predictor R2 F p   β t  p (β) 95% CI 
          
T1 Depression T1 Psychological Flexibility 0.637 19.994 <0.001  0.290 2.716 0.008 0.026, 0.169 
 T1 Psychological Inflexibility      0.271 2.873 0.005 0.033, 0.183 
 T1 Self-Compassion     0.225 2.189 0.031 0.009, 0.196 
          
T3 Depression T3 Psychological Flexibility 0.618 23.910 <0.001  0.238 2.460 0.015 0.019, 0.172 
 T3 Psychological Inflexibility     0.235 2.443 0.016 0.020, 0.188 
 T3 Self-Compassion      0.251 2.514 0.013 0.024, 0.199 
          
T1-T3 Depression T1-T3 Psychological Flexibility 0.557 13.180 <0.001  0.249 2.523 0.013 0.020, 0.164 
 T1-T3 Psychological Inflexibility     0.346 3.573 0.001 0.068, 0.240 
 T1-T3 Self-Compassion     0.144 1.554 0.124 -0.020, 0.161 
          
T1+T3 Depression T1+T3 Psychological Flexibility 0.004 0.112 0.953  -0.013 -0.088 0.930 -0.052, 0.048 
 T1+T3 Psychological Inflexibility     -0.056 -0.429 0.669 -0.063, 0.041 






Table 12 Mediation analyses for psychological flexibility (MPFI), psychological inflexibility (MPFI) and self-compassion (SCS) on mental wellbeing 
            Standardised β Coefficients 
Dependent Variable Predictor R2 F p   β t  p (β) 95% CI 
          
T1 Mental Wellbeing T1 Psychological Flexibility 0.724 32.322 <0.001  0.412 4.315 <0.001 0.090, 0.243 
 T1 Psychological Inflexibility      0.240 2.848 0.005 0.035, 0.196 
 T1 Self-Compassion     0.228 2.480 0.015 0.025, 0.225 
          
T3 Mental Wellbeing T3 Psychological Flexibility 0.532 43.890 <0.001  0.482 5.722 <0.001 0.169, 0.347 
 T3 Psychological Inflexibility     0.192 2.287 0.024 0.015, 0.211 
 T3 Self-Compassion      0.161 1.856 0.066 -0.006, 0.197 
          
T1-T3 Mental Wellbeing T1-T3 Psychological Flexibility 0.405 19.978 <0.001  0.421 4.607 <0.001 0.110, 0.278 
 T1-T3 Psychological Inflexibility     0.306 3.401 0.001 0.071, 0.269 
 T1-T3 Self-Compassion     0.077 0.892 0.375 -0.058, 0.152 
          
T1+T3 Mental Wellbeing T1+T3 Psychological Flexibility 0.012 0.370 0.774  -0.091 -0.628 0.532 -0.082, 0.042 
 T1+T3 Psychological Inflexibility     0.021 0.162 0.872 -0.059, 0.069 







Since self-compassion is positively correlated with psychological flexibility, and negatively correlated 
with psychological inflexibility38, it would be expected that these two measures would change along 
with self-compassion. The slowness of the change may be reflected in the fact that they were not the 
primary targets. The initial improvement in psychological flexibility in the first half of the group may 
be attributable to novel processes, as opposed to the bigger change in self-compassion that occurs 
during the second half of the group, perhaps indicative of skill acquisition. Group cohesion has also 
been shown to predict outcome, and six weeks is considered adequate time for these dynamics to 
develop64.  
Hayes65 comments on the idea that change is not always linear, for example, patterns of change in 
psychotherapies may involve rapid response to treatment, sudden gains in between individual sessions 
and irregular spikes throughout the intervention. This study did not collect outcome measures weekly 
to be able to comment on a specific pattern, but there is evidence here of a nonlinear pattern of 
change, possibly reflective of destabilising and reorganising processes in therapy65.   
The third finding of this study demonstrated self-compassion to be a superior mediator of the 
treatment effect on pain interference, compared to psychological flexibility and psychological 
inflexibility. Both psychological flexibility and inflexibility, however, were found to be better mediators 
of improvements in depression and mental wellbeing, compared to self-compassion. Psychological 
flexibility, psychological inflexibility and self-compassion were not found to mediate improvements in 
anxiety. It is interesting to note that self-compassion mediated the only pain-specific construct being 
measured in this study (pain interference), which suggests that there may be a specific benefit in 
targeting self-compassion within pain interventions.  
These findings partly fit in line with previous research, although appear contradictory in the context of 
studies that have not measured self-compassion, psychological flexibility and psychological inflexibility 
together. For example, in one study, low self-compassion was highlighted as a significant predictor of 




pain disability66. The findings of the current research assert that self-compassion has more dominant 
influence over improvements in pain disability and interference, when compared in the same model. 
It has already been established that feelings of shame and guilt are common in living with chronic 
pain6,8, and it may be the case that targeting these complex, internalised barriers is an efficacious way 
to manage the negative impact of chronic pain.  
According to Vowles67, psychological flexibility mediated improvements in anxiety and depression, 
however, pain acceptance and self-compassion were the strongest overall mediators when all 
mediators were tested in the same model. It was surprising that, in the current study, psychological 
flexibility and inflexibility were found to mediate improvements in depression and wellbeing when the 
current intervention did not have an explicit focus on the concept. This may be explained by 
measurement discrepancies in using different scales (e.g. depression was measured using the British 
Columbia Major Depression Inventory in Vowles’ study, and in the current study, the HADS was used). 
Studies that report a mediating effect of psychological flexibility, psychological inflexibility or self-
compassion on depression also reported similarly for anxiety38,68, which the current findings did not 
support. It may be the case that process variables for improvements in anxiety were attributable to 
common group processes, such therapeutic solidarity, modelling and belonging, or other concepts that 
were not measured in this study (e.g. pain acceptance, thinking styles or control over pain).  
Discrepancies between the current research’s findings and existing literature can be also be a reflection 
of the overlap between the three constructs. Self-compassion has been demonstrated to be the most 
robust mediator in trial of ACT for chronic pain67, even when not explicitly addressed in the 
intervention. In a study where ACT was used as an intervention to promote self-compassion and reduce 
psychopathology, psychological flexibility was established as a significant mediator of changes in self-
compassion69. Others have suggested that ACT, like CFT, can be used to address criticism, stigma and 
shame70, even though this a key element of CFT. The literature is clearly reflecting the conceptual 
overlaps between ACT and CFT. Luoma and Platt70 suggest that although self-compassion is implied in 




explicitly integrating values work to include the relationship with the self. The evidence base would 
suggest that these two approaches can be seamlessly integrated in order to maximise outcomes.  
4.1. Strength and Limitations  
The clinical setting of the intervention is both a strength and a limitation. Comments here are similar 
to those noted by Penlington39, whose research was completed within a similar context. On one hand, 
realistic participant recruitment strengthens external validity; the PMP accepted those with co-
morbidities and no PMP attendees were excluded from the research. This means that the results can 
be better generalised to a wider chronic pain population. On the other hand, internal validity was 
compromised as it was likely that individuals used other personal methods of pain management 
alongside the intervention. As such, it was not possible to deduce whether the gains were solely based 
on completion of the PMP. It was also not possible to estimate the other benefits of participating in a 
group, for example, therapeutic comradery in a supportive, clinical environment. The standardised 
betas of the mediators demonstrated only modest effect sizes, and so, it is entirely plausible that there 
are other factors influencing participant improvement, such as regular exercise, anticipatory hope and 
patient expectation15, therapeutic alliance, therapist effects71 and generic group benefits, such as 
therapeutic solidarity and group cohesion. Demand characteristics are also likely to serve as an 
extraneous variable. 
The attrition rate in this study was 26.2%. This is consistent with the literature in this area, although 
attrition rates for PMPs vary, ranging from 9–42%72. Attrition has been associated with higher levels of 
pain, disability and depression73, employment and disability benefits, literacy difficulties, pain 
catastrophising, history of substance abuse and trauma74, poor self-efficacy and physical function75. In 
order to reduce attrition, Richmond et al.76 recommends the management of unrealistic expectations, 
as well as stressing the importance of self-management and family support. This study did not uncover 
any differences between the pre-group outcome measures (pain, anxiety, depression, psychological 




completers and non-completers, nor between pre-group outcomes and basic demographics. Group 
sizes for the latter analysis were small, which will increase the likelihood of type II errors.  
The use of LOCF is not without bias. This technique is deemed to be a conservative way of handling 
missing data77, but it makes the assumption that the intervention will not cause deterioration below 
pre-group measurements, which may cause an overestimation of the treatment effect. Listwise 
deletion was used on roughly a quarter of the total data (where missing data was greater than 10%). 
This may also increase the likelihood of type II errors, although, this is not considered to be a 
problematic method if missing data is random and the sample size is large enough to remain 
adequately powered59,78, as was calculated a priori.  
Judd, Kenny and McClelland’s61 guidelines for within-subject mediation follows a component approach 
instead of index approach of mediation. The component approach requires joint-significance testing 
of multiple parameter estimates, and therefore, reduces the likelihood of falsely identifying mediation 
of the treatment effect on one dependent variable by a predictor. Overall, however, the large number 
of analyses are likely to inflate the risk of type I errors. 
There was some (albeit limited) regulation around fidelity to treatment in this study. Where possible, 
facilitators attended CFT training. No specific manual exists for CFT adapted for chronic pain, but 
facilitators produced and followed the same week-by-week structure for every group (Appendix 9). 
There was regular supervision for Psychologists (individual and group) from qualified Clinical 
Psychologists in the service. Fidelity to treatment is an area that is poorly documented in 
psychotherapy research. A review by Perepletchikova et al.79 compiled data on randomised controlled 
trials of psychotherapies to investigate which studies systematically addressed treatment fidelity. The 
authors found that only 3.50% of the studies adequately addressed fidelity to treatment, which 
included domains such as treatment adherence, therapist competence and supervision.   
A strength of this study was its longitudinal design and the inclusion of a baseline at assessment (T0), 




showed no significant change in scores of pain intensity, pain interference, anxiety or depression 
before beginning the intervention. This cannot be considered a complete control period because only 
a smaller subset of the questionnaires was collected at assessment (BPI and HADS). This was done 
because these questionnaires are routinely posted out to participants prior to their one-to-one 
assessment with a member of the clinical team. It was not decided at this point whether or not a 
participant was going to be suitable for a PMP, and the extra questionnaires were not added in order 
to reduce participant burden. There was also a varying number of weeks from the date of assessment 
to the pre-group introductory group, and so, further assessment data could not be collected at the 
same time. Nevertheless, inclusion of baseline assessment data suggests that waiting to start a PMP 
does not promote improvement in psychological wellbeing.  
4.2. Conclusion 
To date, this is the first longitudinal study to explore the mediating effects of self-compassion, 
psychological flexibility and psychological inflexibility in a CFT group for chronic pain. The results 
demonstrate the suitability of using CFT as a group intervention for adults with chronic pain. The 
largest improvements were found to occur in the second half of the group, which has implications for 
services in the NHS that are under pressure to provide shorter interventions. Self-compassion, 
psychological flexibility and psychological inflexibility were found to mediate different measures of 
improvements, adding to the sparse evidence base in this area. As well as supporting the use of CFT 
for chronic pain, the results of this research suggest that pain interventions already targeting 
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• Truly representative (random sampling)*  
• Somewhat representative (non-random 
sampling)* 
• Selected group 












3. Sample size • Adequate to detect effect* (based on 
Cohen, 1992) 
• Not adequate to detect effect 
 
  
4. Selection of the 
non-FMS 
cohort? 
• Drawn from the same community as the 
FMS cohort* 
• Drawn from a difference source 




5. Definition of 
non-FMS cohort 
• No history of FMS* 
• No description  
 
  
6. Comparability of 
cohorts on the 




• The study controls for relevant confounders 
(e.g. age, sex, etc)* 






• Specialist medical record (e.g. 
rheumatologist)* 
• Structured interview (including review by 
medic)* 
• Validated measurement tool* 
• Non-validated measurement tool 





• No description 
 
7.1 Demonstration 
that FMS was 
not present at 








8. Assessment of 
outcome 
• Independent blind assessment* 
• Record linkage* 
• Self-report 
• No description 
 
  
9. Response rate / 
follow-up  
 
• Complete follow-up – all subjects 
accounted for* 
• Satisfactory follow-up and satisfactory 
attrition rate ⩾50%* 
• Unsatisfactory follow-up an unsatisfactory 
attrition rate  
• No statement 
 
  
9.1 Was follow-up 




• Yes (2+ years)* 





10. Statistical test • The statistical test used to analyse the data 
is clearly described and appropriate, and 
the measurement of the association is 
presented* 
• The statistical test is not appropriate, not 
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Title of Research 
How do self-compassion and psychological flexibility mediate change in a Compassion-Focused 
Therapy group for people with chronic pain? 
 
Protocol Author 
Su Tin, Trainee Clinical Psychologist 
 
List of Abbreviations 
ACT Acceptance and Commitment Therapy  
CBT Cognitive-Behaviour Therapy 
CFT Compassion-Focused Therapy 
 
Background: The Impact of Chronic Pain  
Chronic pain is pain that lasts longer than 3 months and affects 18% of the Scottish population (NHS 
QIS, 2008). Unlike acute pain, it is not an indication of sinister disease processes. In the process of 
learning to live with chronic pain, people may have experiences of being disbelieved by family, friends 
and health professionals, struggle with beliefs of being a burden on their loved ones and feel 
disappointment at not being able to fulfil previously held roles in the family (Smith & Osborn, 2007). 
Chronic pain becomes a stigma and these experiences, in conjunction with debilitating physical 
symptoms, can have a profound impact on mood, behaviour and general wellbeing. It is not the 
intensity of the pain that affects quality of life; the issue is more relational, for example, the negative 
beliefs that someone may hold about their pain (Lamé et al., 2005). Negative cognitions and emotions 
are activated by pain-related difficulties and multi-disciplinary treatments for chronic pain target the 
management of these internal experiences and daily functioning, rather than attempting to eliminate 
the physical sensation of pain.  
 
Current Treatment Models in Chronic Pain 
Alongside education and physical exercise, Cognitive Behaviour Therapy (CBT) and Acceptance and 
Commitment Therapy (ACT) are used across multidisciplinary pain management programmes in the 
treatment of chronic pain. CBT is recommended by the Scottish Intercollegiate Guidelines Network 
(SIGN) Guideline 136 and ACT is recommended by the American Psychological Association (APA 
Division 12: Society of Clinical Psychology).  
 
CBT aims to identify, examine and alter the impact of distressing, unhelpful cycles of cognition and 
behaviour. Techniques such as graded activation and graded exposure are also used to help achieve 
sustainable levels of activity and reduce avoidance (Williams et al., 2012; Bailey et al., 2010). Mediator 
analyses have identified self-efficacy as the mechanism of change in CBT for chronic pain (Turner et 
al., 2007), which is a construct targeted by many other psychotherapies, not only CBT. Acceptance and 







internal experiences and foster distance between the self and negative thoughts. The overall process 
underlying the methods used in ACT can be conceptualised as ‘psychological flexibility’ (Hayes et al., 
1999). A review by Hughes and others (2017) examined 11 trials, finding significant medium to large 
effect sizes for measures of acceptance and psychological flexibility.  
 
Comparisons between individuals on an ACT and a CBT pain management programme has not 
uncovered significant differences across improvements sustained in pain interference, depression, 
anxiety, and quality of life (Wetherall et al., 2011). Gaudinano (2009) notes that more attention should 
be focused on the mechanisms of action as opposed to pitting separate treatments against each other 
and drawing conclusions about their efficacy based on differences across outcomes. Many 
psychotherapies share constructs and are often shown to result in similar outcomes.  
 
Psychological Flexibility 
Cross-sectional studies do not give explanation into the direction of the relationship between process 
and outcome variables; it is difficult to deduce if outcomes have improved because psychological 
flexibility has increased, or if psychological flexibility has increased because the outcomes have 
improved. A number of cross-sectional studies have, however, proven that psychological inflexibility 
is linked to anxiety, depression and wellbeing (e.g. Masuda & Tully, 2011). Vowles and others (2014) 
performed correlation and regression analyses and reported significant relationships between 
psychological flexibility and measures of disability, emotional functioning, pain acceptance and valued 
activity. Four key process variables of psychological flexibility were investigated by McCracken and 
Gutierrez-Martinez (2011): pain acceptance, values-based action, psychological acceptance and 
mindfulness. General acceptance was found to show the largest effect size, predicting gains in 
outcome more so than those accounted for by pain acceptance. The authors note that the concept 
itself is a tricky idea to capture accurately, because behaviour related to psychological flexibility 
cannot be measured until one has a concept of psychological flexibility, which affects measurement 
of the baseline. 
 
Self-Compassion 
Compassion-focused therapy (CFT) was developed for individuals who struggle with shame and self-
criticism (Gilbert, 2009), both of which can be conceptualised as examples of distressing private 
experiences in the ACT model. It aims to promote a compassionate internal relationship with the self, 
drawing on the ability to view distressing experiences with kindness, understanding and shared 
humanity (Neff, 2003). Shame involves a negative evaluation of the self, unlike guilt, which involves a 
negative evaluation of behaviour (Lutwak et al., 2003). These complex emotions and cognitions are 
relevant in the context of chronic pain because of the experience in losing and adjusting to an identity. 
Purdie and Morley (2016) note that chronic pain is frequently invalidated by society and this constant 
negative social evaluation can result in a shameful appraisal of a person’s sense of self. In this sense, 
CFT targets self-acceptance in the same way as ACT, but from a different perspective by bringing social 
inclusion into awareness. 
 
The positive influence of self-compassion is beginning to be investigated across a range of long-term 
health conditions, such as diabetes (Friis et al., 2015) and cancer (Pinto-Gouveia et al., 2014). To date, 
however, there is little research on self-compassion and chronic pain. Wren and others (2012) found 
that self-compassion was a significant predictor of mood, negative pain beliefs and disability related 
to pain. This cross-sectional study indicated that self-compassion may be significant in predicting pain 
adjustment, but can only comment on association and not causal relationships. The authors suggest 







compassion. Marshall and Brockman (2016) reported self-compassion to significantly correlate with 
processes of psychological flexibility, and self-compassion actually predicted mental wellbeing over 
and above psychological flexibility. This indicates that combining these therapies may result in 
improved treatment outcomes. This study was, however, conducted on a non-clinical population 




There is a need for evidence-based answers to explain why and how psychological interventions are 
successful (Kazdin, 2007). Multimodal treatments are becoming the norm and breaking down these 
components to examine individual efficacies is not a good use of resources (Wicksell et al., 2010). CFT 
offers a complementary approach to be used alongside current interventions, targeting the inevitable 
feelings of shame and self-criticism in the process of adjusting to chronic pain. A strong correlation 
between self-compassion and psychological flexibility has already been established, and gaining 
insight into the direction of the relationship between these concepts and treatment outcome would 
be the next logical step. By focusing on mechanisms of change, better theories can be developed and 
may promote treatment efficacy (e.g. by matching to patient need). This would be a far more efficient 
way to develop interventions, whilst maintaining a person-centred delivery of care. 
 
Principal Research Question 
- Do self-compassion and psychological flexibility mediate change in a Compassion-Focused 
Therapy group for adults with chronic pain? 
 
Secondary Research Questions 






Participants will be adults with chronic pain who attend and complete the CFT-incorporated groups at 
the Lothian Chronic Pain Service / Pain Management Programme.  
 
Inclusion Criteria Exclusion Criteria 
- Chronic Pain lasting a minimum of 3 
months 
- Fluency of English sufficient for 
participation in the group and 
completion of questionnaires 
- Aged 18+ (no upper age limit) 
- Ability to provide informed consent as 
judged by the clinical team 
 
- Active substance misuse 
- Active suicidality 
- Terminal illness 
- Inability to provide informed consent 
(as defined by the Five Statutory 
Principles of the Mental Capacity Act, 










This study will follow a within-group (non-randomised) effectiveness-implementation design (Curran, 
2012). Five self-report measures will be completed by participants at three specified time periods (pre-
, mid- and post-group; see Procedure below). 
 
Recruitment 
2-3 new Pain Management Programme groups start every month, each running for 11 weeks at the 
Astley Ainslie Hospital in Edinburgh. 6 groups run every week and each group is booked for a maximum 
of 15 people. These groups are run by at least two qualified members of the clinical team (Clinical 
Psychologists and Physiotherapists). There will be no need to advertise the research outwith normal 
clinical operations because clinical staff will offer all group participants the opportunity to participate 
in the research during their initial assessment, and data collection will overlap with existing routine 
outcome measures.   
 
Procedure 
Potential participants will be identified through their initial assessment upon referral to the Chronic 
Pain Service. Those who are deemed to be suitable for a Pain Management Programme (e.g. capacity, 
motivation) will be offered an introductory group session, followed by invitation to an upcoming 11-
week group. Information sheets and consent forms will be given out at the start of the group (week 
1), to be completed and returned the following week. The information sheets will contain details about 
the purpose of the research, expectations of the participant in taking part and further information 
about consent, potential benefits, confidentiality and details of the researchers. Participants will be 
given time to consider the information and direct questions to the clinical team, to go home and 
consider the information privately, and also given the opportunity to phone the service and ask further 
questions if desired. Those who can provide written informed consent will complete pre-group 
measures at the start of week 1. Mid-group measures will be completed at the end of week 5 and 
post-group measures will be completed at the end of week 11. (See section 6.4 for details of outcome 
measures.) The clinical team will be available if participants require support to complete the measures 




All groups will follow the same 11-week, structured timetable, using Compassion-Focused Therapy. As 
there are no current guidelines for using CFT in chronic pain, exercises have been adapted from 
‘Compassion Focused Therapy for Dummies’ (Welford, 2016), incorporating the key elements of CFT 
(Gilbert, 2009).  
 
Data Collection 
Demographic information routinely collected by the service will be used for descriptive statistics 
(gender, age, area of residence, pain diagnoses and other relevant physical health conditions, duration 
of pain, employment status and recent pain-related contact with healthcare services). The following 
self-report measures will be completed by participants at the beginning of week 1 (start) and at the 
end of week 11 (end). Questionnaires denoted with ‘*’ will be completed by participants at these time 
intervals and, additionally, at week 5 (mid-point). 
 
Anxiety and Depression* 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) is a 14-item measure of 







Each of the items are scored from 0 to 3, where a higher score depicts greater frequency or intensity 
of the described symptom over the last week (e.g. “I get sudden feelings of panic” and “I have lost 
interest in my appearance”). Anxiety and depression are rated separately, each allowing for a 
minimum score of 0 or a maximum score of 21. Bjelland et al. (2002) reviewed 747 papers using the 
HADS and demonstrated a two-factor structure (i.e. anxiety and depression), with a high level of 
internal consistency for both the anxiety (Cronbach’s α = .83) and depression (Cronbach’s α = .82) 
subscales. Michopoulos et al. (2008) reported a high test-retest reliability of .94 over a 20-day period.   
 
Mental Wellbeing* 
The shortened version of the Warwick-Edinburgh Mental Wellbeing Scale (Taggart et al., 2015) 
(SWEMWBS; Stewart-Brown et al., 2009) is a 7-item measure reporting on subjective positive mental 
wellbeing and psychological functioning over the last two weeks. It aims to cover a broad range of 
positive mental health concepts (e.g. “I’ve been feeling confident” and “I’ve been feeling close to other 
people”) but does not include spirituality or socioeconomic factors. Each of the items on the measure 
require a response on a Likert scale, from 1 (none of the time) to 5 (all of the time). This yields a 
minimum score of 7 and a maximum score of 35 (higher score indicating greater well-being). The 
SWEMWBS has a test-retest reliability of .83 and demonstrates stability after one week (Stewart-
Brown et al., 2009).  
 
Pain 
The Brief Pain Inventory (short form, BPI-SF; Cleeland & Ryan, 1994) is a 9-item measure designed to 
capture two aspects of pain: pain interference (with daily living) and pain severity. These two distinct 
dimensions have been confirmed through factor analysis. Responses to items on this measure range 
from 0 (does not interfere) to 10 (completely interferes) on the pain interference subscale and 0 (no 
pain) to 10 (pain as bad as you can imagine) on the pain severity subscale. The BPI-SF demonstrates 
stable test-retest reliability and high internal consistency, with Cronbach’s α ranging from .80 to .92 
(Cleeland, 2009). The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
(IMMPACT; Dworkin et al., 2005) recommends that all chronic pain research should include outcomes 
in pain interference and pain severity. 
 
Self-Compassion* 
Self-Compassion Scale (short form, SCS-SF; Neff, 2003) is a 12-item measure designed to assess a 
person’s kindness and understanding towards themselves during difficult times. The three elements 
of self-compassion as defined by Neff (2003) exist on a dichotomy: self-kindness vs. self-judgement; 
common humanity vs. isolation; and mindfulness vs. over-identification. Responses to these items are 
indicated on a Likert scale, ranging from 1 (almost never) to 5 (almost always). The SCS-SF has a strong 
correlation with the long form measure, and factor analysis has validated the six-factor model, in 
addition to the single higher-order factor of self-compassion (Raes et al., 2011). The SCS-SF shows high 
internal consistency (Cronbach’s α = .86; Raes et al., 2011) and good test-retest reliability over three 
weeks (scores of at least .8 across all subscales; Neff, 2003).  
 
Psychological Flexibility* 
Multi-Dimensional Psychological Flexibility Inventory (short form, MPFI-SF; Rolffs et al., 2016) is a 24-
item measure assessing the flexibility of a person’s response to negative internal experiences (e.g. 
thoughts and feelings). Psychological flexibility allows a person to carry these negative experiences 
whilst living their life in a meaningful, values-directed way. Twelve dimensions have been validated in 
the 6-factor model of psychological flexibility (Rolffs et al., 2016), the Hexaflex model (Hayes et al., 







self-as-context, defusion and acceptance. Psychological inflexibility encompasses lack of contact with 
the present moment, lack of contact with values, inaction, self-as-content, fusion and experiential 
avoidance. Response to items range from 0 (never true) to 6 (always true) of items in the context of 
the last two weeks. The MPFI has been shown to have higher levels of internal consistency than other 
measures of psychological flexibility (Rolffs et al., 2016). 
 
Sample Size 
Fritz and MacKinnon (2007) propose guidelines for recommended sample sizes in order to detect 
mediation effects with .8 power. These guidelines are informed by existing literature in the field. There 
is less robust research on self-compassion and chronic pain, therefore, this calculation is based on 
research in psychological flexibility and chronic pain.  
 
McCracken and Gutierrez-Martinez (2011) conducted correlational analyses on the processes of 
psychological flexibility following a group intervention based on ACT. These processes included 
acceptance of pain, mindfulness, psychological acceptance and values-based action (r values between 
0.33 and 0.55). These positive correlations indicate that the group intervention was related to higher 
levels of psychological flexibility. A review by Hayes and others (2006) identified several studies that 
reported correlational effect sizes between acceptance, and depression/anxiety/daily functioning 
related to chronic pain (r = -0.58/-0.66/0.47 respectively). These negative correlations illustrate that 
higher levels of psychological flexibility were related to better outcomes. Based on these correlational 
effect sizes, Fritz and MacKinnon's guidelines suggest that a sample size of 53-71 is required. 
 
Analysis 
The analysis will focus on the proposed mediating factors (self-compassion and psychological 
flexibility) and how they explain the outcome of the CFT-incorporated group intervention. In order to 
study the processes of change, this study will measure change in mediators and outcomes over the 
course of the group. In a mediation model, the effect of the independent variable (IV; CFT group) on 
a dependent variable (DV; outcome/change in symptoms) is conveyed through a third mediating 
variable. In order to be a mediator, a variable must change during the intervention, be associated with 
the intervention, and have an impact on the outcome. 
 
In this study, it is hypothesised that self-compassion and/or psychological flexibility are the mediating 
variables that explain the influence of the group intervention on eventual outcome, i.e. the overall 
change in symptoms at the end of the group. Linear regression and nonparametric bias-corrected 
bootstrap, which corrects for skew in the data, will be applied to the data using SPSS, using the 
PROCESS macro. An effect of mediation will be indicated if the confidence interval does not contain 
zero. Missing data will be handled using either the maximum likelihood or multiple imputation 
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Appendix 6: Participant Information Sheet 
 
Version 2 (25/01/18) 
  
Information Sheet for Participants 
Pain Management Research Project 
 
You are being invited to take part in a doctoral research project. Before you 
decide if you would like to take part, we would like you to understand why 
we are doing this research and what it involves.  
 
Please take time to read the following information carefully and discuss it with 
others if you like. This information sheet tells you the purpose of the research, 
what will happen if you agree to take part and how it will be carried out. If there 
is anything that is not clear, or if you would like more information, please speak 
to the clinical staff at the Pain Management Service or contact the researcher 
(contact details at the end of the information sheet). Take your time to decide 
whether or not you wish to take part.  
 
What is the purpose of the research? 
This research aims to study how Compassion-Focused Therapy in a Pain 
Management Programme might work for people with chronic pain. We know 
that Pain Management Programmes help patients to manage their pain and 
improve quality of life, and this research will look into the processes by which 
this happens. In particular, this research will look at two psychological 
concepts: ‘self-compassion’ (kindness to self) and ‘psychological flexibility’ 
(willingness to tolerate difficult experiences in order to meet meaningful goals). 
These concepts help us understand how we think about ourselves in the 
context of pain.  
 
Why have I been invited to take part? 
You have been invited to take part in this research because you have been 
referred to NHS Lothian’s Pain Management Service, and after assessment, you 
have been offered a place on a Pain Management Programme.  
 
Do I have to take part?  
No, it is up to you to decide whether or not to take part. If you agree to take 
part, please complete the consent form and questionnaires given to you at the 






week. If you decide to take part you are still free to withdraw at any time, 
without giving a reason. Deciding not to take part or withdrawing from the 
study will not affect the care you receive from the Pain Management 
Programme. 
 
What will happen if I take part? 
You will be given a consent form at the start of the group (week 1). You will be 
asked to complete five questionnaires at the start (week 1), middle (week 5) 
and end (week 11) of the group. The questionnaires at the start and end of the 
group are already routinely used to ensure that we are helping people and that 
the service is useful. These questionnaires are simple measures of things 
important to people with chronic pain, such as pain intensity, mood, sense of 
well-being, and other measures of how we feel about ourselves and how we 
respond to difficult things in life. The only active difference between 
participating and not participating in this research is the extra questionnaires 
you will be asked to complete in the middle of the group.  
 
What are the possible benefits of taking part? 
The information we gain will help us to understand how Compassion-Focused 
Therapy in a Pain Management Programme works. By doing so, we hope that 
treatments for chronic pain may evolve faster and more efficiently. You may 
get some satisfaction from being a part of this process.  
 
What are the possible disadvantages and risks of taking part? 
Completing the questionnaires at week 5 will take 20-25 minutes. It is unlikely 
that you will experience any negative effects from taking part in this research. 
There is a possibility that you may find some of the questionnaires upsetting. If 
this happens, you are welcome to speak to a member of the clinical team who 
will be present every week. Alternatively, further support can be accessed 
through Breathing Space (0800 83 85 87) or The Samaritans (08457 90 90 90). 
  
Will my taking part be kept confidential? 
Your data will be analysed by the researcher (Su Tin, Trainee Clinical 
Psychologist), the Pain Management team and other authorised people to 
check that the research is being carried out correctly. All are bound by a duty 
of confidentiality to you as a participant. If you decide to take part in the 
research, your data will be anonymised so that you cannot be identified from 
your questionnaires. The data is stored on a secured NHS database and all 
consent forms and paper questionnaires are kept in a locked drawer in a secure 






and anonymised research data will be reviewed for retention or disposal every 
5 years.  
 
What will happen to the results of the research? 
The results of this research will be written up as a doctoral thesis submitted to 
the University of Edinburgh. This will also take the form of an article submitted 
to a peer-reviewed journal and may be presented at academic conferences. 
You will not be identified in any report or publication. Please contact us if you 
would like a copy of the published results.  
 
Who is organising the research and why? 
The research is sponsored by the University of Edinburgh and NHS Lothian. It 
has been organised by the researcher as part of their doctoral thesis. 
 
Who has reviewed the research? 
The study proposal has been reviewed by the Ethics Committee at the 
University of Edinburgh. All research in the NHS is looked at by an independent 
group of people called a Research Ethics Committee. A favourable ethical 
opinion has been obtained from the East Midlands (Nottingham 1) REC. NHS 
management approval has also been obtained. 
 
Thank you very much for reading this information. If you have any further 
questions about the study, please contact me on the details below. 
 
Su Tin 




Pain Management Service 
Astley Ainslie Hospital 








Dr David Gillanders 
Head of Clinical/Health Psychology 
University of Edinburgh 
School of Health in Social Science 
Teviot Place 
Edinburgh, EH8 9AG 
 





Dr Shona Brown 
Clinical Psychologist 
Pain Management Service 
Astley Ainslie Hospital 
133 Grange Loan 
Edinburgh, EH9 2HL 
 




If you wish to make a complaint 
about the research please contact: 
 
Patient Experience Team 
NHS Lothian, 2nd Floor 
Waverley Gate 
2-4 Waterloo Place 
Edinburgh, EH1 3EG 
 




If you would like to discuss this study 
with someone independent of the 
study team, please contact Dr 
Caroline Cochrane on: 
 









Appendix 7: Consent Form  
 
  
Participant Consent Form 
 
Pain Management Research Project 
 
 
Title of Research 
How do self-compassion and psychological flexibility mediate change in a 
Compassion-Focused Therapy group for chronic pain? 
 
Research Summary 
This research aims to study how Compassion-Focused Therapy in a Pain 
Management Programme might work for people with chronic pain by looking 
into the psychological processes through which change occurs. 
 
 Please initial  
I have read and understood the Participant Information Sheet 
(v2 25/01/18) for the above study and have had the 
opportunity to consider the information and ask questions. 
 
 
I understand that my participation is voluntary and I am free 
to withdraw at any time, without giving a reason, without my 
medical care being affected. 
 
 
I understand that the treatment I receive will be unaffected by 
participating in the above study. 
 
 
I understand that my anonymised data will form part of a 









I understand that relevant sections of my medical notes and 
data collected during the study may be looked at by 
individuals from the regulatory authorities and from the 
Sponsors (NHS Lothian and the University of Edinburgh) or 
from the/other NHS Board(s) where it is relevant to my taking 
part in this research. I give permission for those individuals to 
have access to my records. 
 
 







_________________________________    
 
Participant’s name (Printed)      
 
_________________________________   _________________________________ 
 
Participant’s signature                Date 
 
_______________________________   
Person taking consent (Printed)  
 
_________________________________  _________________________________ 
 
Signature of person taking consent          Date 
 
 






Appendix 8: Participant Questionnaire Pack  
 
 
LOTHIAN CHRONIC PAIN SERVICE 










We know that living with pain is difficult. We know it affects what you can and can’t 
do, and we know it affects how you feel. The following questionnaires will help us to 
determine how best we can help you, as well as being able to provide indications of 
your progress at the end of the Pain Management Programme. 
 
 
Remember to answer all of the questions, as best you can, on both sides 




If you have any questions about these questionnaires, you can contact us on 
0131-537-9128 (Astley Ainslie Hospital). Thank you for taking the time to 








About the intensity of your pain 
 
 
Please rate your pain by circling one number that best describes how sore your pain is: 
 
At its WORST in the last 24 hours   
0 1  2 3 4 5 6 7 8 9 10 
No            Pain as bad 
Pain            as you can 
            imagine 
At its LEAST in the last 24 hours        
0 1  2 3 4 5 6 7 8 9 10 
No            Pain as bad 
pain            as you can 
            imagine 
On the AVERAGE         
0 1  2 3 4 5 6 7 8 9 10 
No            Pain as bad 
pain            as you can 
            imagine 
RIGHT NOW           
0 1  2 3 4 5 6 7 8 9 10 
No            Pain as bad 
pain            as you can 
            imagine 
 
 
About the interference with life 
 
Please circle one number that describes how, during the past 24 hours, pain has interfered with your: 
 
General activity          
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere           interferes 
Mood            
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere           interferes 
Walking ability          
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 









Normal work (includes both work outside the home and housework) 
 
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere           interferes 
Relations with other people         
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere           interferes 
Sleep            
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere           interferes 
Enjoyment of life          
0  1  2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere           interferes 
 
 

















The Short Warwick-Edinburgh 
 






Below are some statements about feelings and thoughts. 
 
Please tick the box that best describes your experience 




Statements None Rarely Some Often All of 
 of the  of the  the 
 time  time  time 
I’ve been feeling optimistic 1 2 3 4 5 
about the future      
      
I’ve been feeling useful 1 2 3 4 5 
      
I’ve been feeling relaxed 1 2 3 4 5 
      
I’ve been dealing with 1 2 3 4 5 
problems well      
I’ve been thinking clearly 1 2 3 4 5 
      
I’ve been feeling close to other 1 2 3 4 5 
people      
I’ve been able to make up my 1 2 3 4 5 
own mind about things      








“Warwick Edinburgh Mental Well-Being Scale (WEMWBS) © NHS Health Scotland, 

























Appendix 9: PMP Timetable 
 
